A Bicyclic L-Proline Derived Chiral Auxiliary for Asymmetric Synthesis by Emberson, Kassandra
  
 
A Bicyclic L-Proline Derived Chiral Auxiliary for Asymmetric 
Synthesis  
 
 
Kassandra A. Emberson, BSc. 
 
Department of Chemistry 
Submitted in partial fulfillment of the requirements for the degree of 
 
Master of Science 
Faculty of Mathematics and Science, Brock University 
St. Catharines, Ontario 
©2015 
 
ii 
 
Abstract 
This thesis describes the use of an L−proline-derived chiral auxiliary for 
diastereoselective lithiation and ligand synthesis. Such compounds have been utilized in 
the Metallinos research group previously for the synthesis of N−substituted planar chiral 
ferrocenes. The first project describes the use of this chiral auxiliary as a directing group 
for N−benzyl substitution, providing products in up to 10:1 diastereomeric ratio (dr). 
These derivatives may serve as chiral ylidene precursors to serve as ligands in transition 
metal catalysis. In addition, an N−substituted planar chiral ferrocene ylidene ligand 
derived from the same chiral auxiliary was used to prepare rhodium complexes that were 
explored as potential catalysts for asymmetric hydroformylation.   
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1. Introduction 
Pharmaceutical and agrochemical industries require a high level of stereochemical 
purity in the compounds supplied to market, and this necessity has been a driving force in 
continuous research towards the development of new chiral ligands and catalysts. A 
stereochemically pure organic compound can be accessed by manipulating an 
enantiopure starting material, through resolution of a racemic mixture, through 
asymmetric catalysis, desymmetrization of meso compounds, or enzymatic catalysis 
applied to achiral compounds. A good chiral auxiliary provides enantiomerically pure 
compounds, but also allows for subsequent manipulation using simple reagents. 
Asymmetric catalysis involves the creation of new stereocentres, through the use of a 
chiral catalyst or enzyme.
1
 
Transition metal catalyzed reactions used on industrially scale for the manufacture of 
organic compounds include oxidation, hydrogenation, and hydroformylation, 
isomerization,  polymerization, cyclooligomerization and alcohol carbonylation.
2
 Modern 
organic synthesis relies on metal catalyzed reactions.  Other metal catalyzed reactions 
improve the general rate and generality of a transformation, such as Buchwald−Hartwig 
amination. Others increase reaction selectivity, for example asymmetric hydrogenation.
3
 
This thesis outlines the extension of the use of our group’s chiral auxiliary derived 
from L−proline. The use of this chiral auxiliary has been established in the synthesis of 
N−substituted planar chiral ferrocenes. The extension of this chiral auxiliary to N−benzyl 
substituted derivatives by diastereoselective lithiation will be presented. The application 
2 
 
of a previously synthesized rhodium−ferrocenyl−ylidene complex to hydroformylation 
will also be discussed.  
2. Historical 
2.1 Asymmetric lithiation−substitution α to nitrogen 
Asymmetric lithiation−substitution α to nitrogen was initially considered 
infeasible because the protons α to nitrogen were not acidic enough to be deprotonated, 
even if strong bases were used.
4
 However, incorporation of a carbonyl group proximal to  
the nitrogen atom served to activate the compound, by increasing the α proton’s acidity, 
as well as allowing for a coordination site with the lithium base. This discovery initiated a 
new field of study to prepare chiral pyrrolidines, first as racemates and later as single 
enantiomers.
5
 The employment of homochiral diamine additives, such as (−)−sparteine, 
in lithiation−substitution reactions provided highly enantiomerically enriched products, in 
addition to regiochemical control. Diastereoselective lithiation−substitution is a route to 
stereochemically pure compounds bearing more than one chiral centre, wherein an 
existing chiral centre dictates the asymmetric lithiation−substitution.  
2.2 Enantioselective lithiation 
  Enantioselective lithiation involves a chiral base or an organolithium coordinated to a 
chiral ligand that can distinguish between two prochiral protons, selectively 
deprotonating one of them to generate a new chiral centre, in a highly enantioselective 
fashion. One of the most widely used chiral ligands is (−)−sparteine (Figure 1).6 The first 
enantio−induced lithiation α to a heteroatom utilizing an organolithium in conjunction 
with (−)−sparteine was reported by Hoppe, Scheme 1.7 
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Figure 1. Structure of (−)−sparteine 
 
 
 
Scheme 1. The first enantioselective lithiation using (−)−sparteine/sBuLi.  
 
A similar approach was then applied to N−Boc pyrrolidine by Beak, affording 
2−substituted N−Boc pyrrolidines in moderate to good yield, with excellent 
enantioselectivitities, Scheme 2.
8
 An organolithium base and (−)−sparteine form a 
complex in solution, that further complexes to the carbamate directing group forming a 
prelithiation complex, thus differentiating between  the two prochiral hydrogens and 
allowing for one to be selectively deprotonated.  
 
 
 
 
Scheme 2. Enantioselective lithiation of N−Boc pyrrolidine. 
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The transmetalation of stannane 6 was used to confirm that deprotonation was the  
enantioselective step of the reaction, Scheme 3.
9
  Since there is no erosion of 
enantiomeric excess in the transmetalation that occurs in the absence of (−)−sparteine, 
this experiment confirmed that the stereoselectivity arises from an asymmetric 
deprotonation. The transmetalation from tin to lithium then occurred with retention of 
configuration to furnish 7 with high enantiopurity.  
 
 
 
Scheme 3. Transmetalation from tin to lithium followed by electrophile quench. 
 
Dieter developed a method to introduce an allyl group adjacent to nitrogen for a series of 
substrates in 2001, Scheme 4.
10
 Later, the Pd catalyzed α arylation of N−Boc pyrrolidine 
was reported by Campos and co−workers, Scheme 5.11  
 
 
 
 
 
Scheme 4. Allylation of N−Boc pyrrolidine. 
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Scheme 5.  Enantioselective Pd catalyzed α−arylation of N−Boc pyrrolidine carbanion. 
 
Metallinos and co−workers showed that asymmetric lithiation in the presence of  
(−)−sparteine can be applied to urea−fused piperidines, further expanding the scope of 
this chemistry. Following a similar protocol, phenanthroline−derived urea 11 was 
deprotonated and subjected to electrophile quench with a variety of electrophiles, 
resulting in low yields and moderate enantioselectivities.
12
 The equatorial pro−S proton is 
removed preferentially, which follows the trend observed for N−Boc protected 
pyrrolidines and piperidines, Scheme 6.
13
 
 
 
 
Scheme 6. Asymmetric lithiation of fused phenanthroline−derived urea 11. 
 
Despite the availability of highly enantio−enriched products produced by asymmetric 
lithiation utilizing (−)−sparteine as a chiral ligand, there is limited access to the opposite 
enantiomers resulting from the lack of availability of (+)−sparteine. Other chiral diamines 
have been synthesized, acting as (+)−sparteine surrogates, to provide access to opposite 
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enantiomers. Beak and co−workers synthesized 20 chiral diamines, but none provided 
enantio−selectivities comparable to sparteine, Figure 2.13 
 
 
Figure 2. Chiral diamines studied by Beak and co−workers. 
 
O’Brien produced a (+)−sparteine surrogate, whose use provides excellent 
enantioselectivity in kinetically controlled deprotonation, but poor selectivity in dynamic 
thermodynamic reactions compared to (−)−sparteine, Scheme 7. 14 
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Scheme 7. Enantioselective lithiation of N-Boc pyrrolidine utilizing (+)−sparteine 
surrogate. 
 
  Wiberg and Bailey completed a computational study of  the interactions of diamine 16 
to investigate where the lack of selectivity in the lithiation of N-Boc pyrrolidine was 
arising. They determined that a lack of steric interaction between 16 and N-Boc 
pyrrolidine was to blame, and suggested that a trans diaminocyclohexane with branched 
alkyl groups might provide better selectivity than 16.
15
 
The Alexikis group developed additional diamine ligands and synthesized another class 
of (+)−sparteine surrogates, chiral cyclohexyl diamines.16 The application of these chiral 
cyclohexyl diamines were examined by O’Brien in the asymmetric deprotonation of 
N−Boc pyrrolidine in 2008, Scheme 8.17 
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In recent years, (−)−sparteine has also become scarce and thus the search for both 
(−)−sparteine and (+)−sparteine surrogates is earnest. To this end, O’Brien and 
co−workers have improved access to the (−)−sparteine surrogate through a multi−gram 
synthesis of the racemic sparteine surrogate followed by  diastereomeric salt resolution 
with (−)−O,O’−di−p−toluoyl−L−tartaric acid, Scheme 9.18 
 
 
Scheme 8. Chiral diamine ligand screening for the asymmetric lithiation of N−Boc 
pyrrolidine. 
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Scheme 9. Synthesis and resolution providing (−)−sparteine surrogate 15. 
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Precomplexation of nitrogen with boron trifluoride or borane has been used to increase 
the regioselectivity of lithiation−substitution α to nitrogen in tertiary amines. The 
lithiation of sp
3−hybridized carbon atoms α to nitrogen in cyclic amines is well known 
with isoindolines,
19
 Trӧeger’s base,20 indolizidines,21 and pyrrolidines.22 Lithiation of 
prochiral α methylene positions in the presence of (−)−sparteine, followed by electrophile 
quench yielded enantio−enriched products, Scheme 10.19, 22 
 
 
 
Scheme 10. Enantioselective lithiation−substitution of an isoindoline−borane complex.15a 
 
Kessar and coworkers reported in 2008 that aniline-BF3 complexes undergo 
ortho−lithiation of an sp2−hybridized carbon at much lower temperature (− 78 °C) than is 
required for free anilines (refluxing hexane). Soon after, Metallinos’s group demonstrated 
that BF3 activation of dimethylaminoferrocene promotes lithiation at – 40 °C. Since 
tertiary aminoferrocenes are prochiral, asymmetric deprotonation is possible. In 2010, 
Metallinos and coworkers reported that BF3−activated tertiary prochiral aminoferrocenes 
asymmetric deprotonation. This  BF3−activation  method  provided access to a variety of 
2−substituted−1−amino−ferrocenes, with high enantiomeric excess after a single 
recrystallization, Scheme 11.
23
 
 
11 
 
 
 
 
 
 
 
Scheme 11. Enantioselective lithiation of BF3 activated tertiary aminoferrocenes. 
 
2.3 Diastereoselective lithiation 
Gawley developed piperidinyl oxazolines which undergo diastereoselective 
lithiation−substitution in good yield with excellent diastereoselectivity, Scheme 12. 
Alkylated products 39a and 39b could then be hydrolyzed and undergo oxidative 
cleavage to produce  chiral primary amines in high enantiomeric purity.
24
 
Following Gawley, Beak and coworkers examined the lithiation of chiral bicyclic 
carbamates, Scheme 13. The results demonstrated that the bicyclic carbamates undergo 
diastereoselective lithiation and provide syn diastereomers as the sole products. Two 
competition experiments between bicyclic carbamates and N−Boc pyrrolidines were also 
conducted to demonstrate that the bicyclic carbamates undergo more facile lithiation than 
the amines. Computational investigations demonstrated that the kinetically favoured 
lithiation involves the removal of a pro−S hydrogen, which is closer to the carbonyl 
oxygen (2.78 Å) than the pro−R hydrogen (3.70 Å), Figure 3.25  
12 
 
 
 
 
 
 
 
Scheme 12. Diastereoselective lithiation and electrophile quench of piperidinyl 
oxazolines 37. 
 
 
 
 
 
Scheme 13. Diastereoselective lithiation and substitution of bicyclic carbamates. 
25
 
 
 
 
 
Figure 3. Depiction of syn versus anti carbanions. 
25
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Metallinos and coworkers published the synthesis of enantiomerically enriched  
pyrrolo[1,2−c]imidazolin−3−ones and pyrrolo[1,2−c]imidazol−3−ones in 2010 that are 
difficult to prepare by conventional methods.
26
 Unsaturated urea 43 was synthesized via 
enantioselective lithiation and substitution in the presence of (−)−sparteine.  The existing 
chiral centre present in the saturated congener 42 allowed for diastereoselective lithiation, 
using TMEDA as an achiral diamine additive to give 44, Scheme 14. 
26
  Products with up 
to 99% enantiomeric excess were achieved in the case of 43. Some of these derivatives 
were converted to precursors for ligands. 
 
Scheme 14. Diastereoselective lithiation and electrophile quench of saturated and 
unsaturated ureas 42. 
26
 
 
Removal of the tert−butyl group in the preceding products 43 and 44 required a 48 hour 
reflux in trifluoroacetic acid and thioanisole. Thus, a more easily removable protecting 
group was desired. Hoppe had previously reported the ortho−metalation of N−silyl 
protected O−aryl carbamates, in which the silyl protecting group was easily removed 
under basic or acidic conditions to provide ortho−substituted phenols 47  (Scheme 15).27 
14 
 
 
Scheme 15. Ortho−metalation of N−silyl protected O−aryl carbamates.27 
 
The Metallinos group utilized an N−silyl protecting group strategy for urea 49 
derived from L-proline hydantoin. Thus reduction of 48 with lithium aluminum hydride, 
followed by protection with triethylsilyl chloride provided 49 as a single enantiomer. 
This substrate underwent lithiation and electrophile quench, providing products with up 
to 95:5 dr. The N-silyl protecting group was easily removed in methanol at room 
temperature, with 2 M hydrochloric acid (Scheme 16). Urea 51 was utilized in the 
synthesis of chiral guanidines.
28
 
 
 
 
 
 
 
Scheme 16. Diastereoselective lithiation and substitution of N−triethylsilyl urea 49. 28 
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Previous work in the Metallinos group involving the synthesis of planar chiral 
ferrocenes utilized phthalimidine as a directing group. N-Ferrocenyl phthalimide 52 was 
prepared from ferrocene following the literature procedure of Sato, by copper mediated 
coupling of iodoferrocene and phthalimide.
29
 Subsequent reduction and protection 
furnished ferrocenyl phthalimidine 53 with a β-ferrocenyl stereocentre. When 53 was 
subjected to lithiation−substitution with LDA and TMSCl, the 2-silylated product 54 was 
obtained as the major product, with aryl-substituted products 56 and 57 accounting for 
less than 5% of the yield. Compound  55 was observed to the diastereomerically pure by 
1
H and 
13
C NMR, showing  ≥95:5 dr (Scheme 17).30 
 
 
Scheme 17. Diastereoselective lithiation−substitution of phthalimidine 54. 
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The utility of L−proline hydantoin in the synthesis of 51 prompted exploration 
into its application for the synthesis of planar chiral ferrocenes. A copper−mediated 
coupling between iodoferrocene 58 and L−proline hydantoin 48 furnished N−ferrocenyl 
hydantoin 59. Reduction with Schwartz reagent selectively reduced the amide carbonyl to 
the corresponding hemiaminal, which could be protected in situ with triethylsilyl chloride 
to obtain a 10:1 mixture of syn/anti epimers. Recrystallization provided only the syn−61 
isomer in 80% yield, Scheme 18. 
31
 Diastereoselective lithiation−substitution of syn−61 
furnished products with ≥95:5 dr, in both in situ electrophile quench with lithium amide 
bases and direct quench with tBuLi, Scheme 19.
31
 After obtaining substituted products 62 
in high diastereomeric purity, they were subsequently converted to the corresponding 
ferrocenyl imidazolones 63 exploiting the inherent lability of the silyl protecting group 
(Scheme 20).
31
 
 
Scheme 18. Synthesis of syn−61. 
17 
 
 
Scheme 19. Diastereoselective lithiation−substitution of syn−61 with ≥ 95:5 dr. 
 
Scheme 20. Acid catalyzed elimination of derivatives 62a−f,h and cyclization of 62g. 
 
18 
 
When benzophenone adduct 62g was subjected to the same conditions, 
cyclization to the annulated urea 64 occurred instead of the expected elimination to the 
corresponding imidazolone.
32
 A diastereomeric mixture (4:1) of anti−64 to syn−64 was 
obtained, but when the reaction was carried out on a larger scale, only anti−64 was 
obtained. This is rationalized by the proposed reversibility of the formation of the 
iminium intermediate. The unusual structure of anti−64 prompted the exploration of 64  
as a precursor in the preparation of an iridium catalyst. The urea carbonyl of anti−64 was 
reduced with DIBAL to aminal 65, followed by oxidation to the imidazolium salt 66 with 
trityl tetrafluoroborate. Treatment with KOtBu generated the imidazolylidene in situ, 
which reacted with Ir(COD)Cl dimer to form 67 as a mixture of coordination isomers. It 
was determined that stirring at room temperature for 16 hours allowed for equilibration of 
the minor isomer to the major isomer, Scheme 21. Conversion to the cationic complex 68 
was achieved by replacement of chloride with triphenyl phosphine followed by an anion 
exchange. 
32
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Scheme 21.Synthesis of an annulated chiral N−ferrocenyl imidazolinium salt and 
complexation to Ir(I). 
 
2.4 Benzylic lithiation 
There are three main types of benzylic lithiation: enantioselective, diastereoselective, and 
lateral. These three main types can be further categorized by the mechanism in which 
they provide stereoselectivity, either through an asymmetric deprotonation resulting in a 
configurationally stable benzyllithium, or through an asymmetric substitution, in which a 
racemic benzyllithium in the presence of a chiral ligand furnishes an enantiomerically 
enriched product. Heteroatom directing groups are utilized to activate the benzylic 
position to lithiation, the most prominent directing groups containing oxygen, sulphur, 
and nitrogen. Nitrogen directing groups have been less developed than oxygen containing 
directing groups, and like their oxygen counterparts, can provide useful synthetic 
20 
 
intermediates upon further derivatization. Figure 4 shows comprehensive list of the 
nitrogen directing groups that have been utilized in benzylic lithiation.
33
  
 
Figure 4. Nitrogen directing groups used to date in benzylic lithiation. 
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Enantioselective lithiation with nitrogen directing groups have several examples of both 
asymmetric deprotonation and substitutions, and thus mechanistic studies must always be 
completed to determine the origin of stereoselectivity. High enantioselectivities (> 99:1) 
have been achieved through the use of (−)−sparteine as a chiral ligand in both 
asymmetric deprotonation and substitution, A-F, Figure 4.
33a-d
  Diastereoselective 
lithiation is used less frequently, the primary examples being reported by Gawley, with 
high diastereomeric ratios of up to 98:2 achieved for G, Figure 4.
33e, 33f
  The lack of 
further functionalization, other than to the corresponding benzyl amines for G and H, 
may explain the lack of application for this chemistry. However, this area may see a 
resurgence, as the lack of a reasonable and reliable source of (−)−sparteine experienced in 
recent years shows no signs of improving. Lateral benzylic lithiation with nitrogen 
directing groups are even more scarce with K showing an amide directing group, in 
which the nitrogen is part of the directing group but in a more remote fashion than in J, 
Figure 4.
33g
  In both cases, high enantioselectivity was observed, operating through an 
asymmetric substitution.   
Benzyllithiums tend to have a low configurational stability, resulting from anion 
stabilization via the adjacent π system of the aromatic ring. This lends more π character to 
the carbon−lithium bond, increasing the degree of planarity. This increased planarity of 
the lithium bearing carbon centre  may result in an increased rate of racemization, thereby 
making the stereoselectivity of benzylic lithiation−substitutions more unpredictable.34 
Primary benzyl carbamates are not known to be configurationally stable even at – 78 °C, 
but the rate of enantiomerization of the coordinated lithiated intermediate may be slower 
than its rate of reaction with an electrophile, as demonstrated by primary benzyllithium 
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69 in Scheme 22. Path A shows enantiotopic differentiation, which provided only a 
moderate er of 66:34 (R: S). Employing a more sterically demanding bis (oxazoline) 
ligand 70 allowed for dynamic thermodynamic resolution (path B), which furnished 
products with a high enantiomeric ratio of 99:1 (S: R). Dynamic thermodynamic 
resolution occurs when two diastereomers can interconvert under the conditions in which 
the benzyllithium is formed. The product ratios that result from dynamic thermodynamic 
resolution are determined by the stability of these diastereomeric intermediates and are 
independent from the electrophile. 
 
Scheme 22. Comparison of enantiotopic differentiation and dynamic thermodynamic 
resolution for 69 arising from chiral ligand choice. 
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   There are two known classes of configurationally stable secondary 
benzyllithiums: carbamates and sulfones. The presence of oxygen atoms in both 
carbamates and sulfones allows for coordination with the lithium ion, locking the 
intermediate in an orientation that makes one face more accessible.
35
 A method for 
testing the configurational stability of benzyllithium intermediate was developed by 
Hoffman, thereafter known as the Hoffman test.
36
 This test involves two experiments 
with the racemic benzyllithium. One experiment is done by trapping the racemic 
benzyllithium with a racemic electrophile. The second involves trapping of the racemic 
benzyllithium with an enantiomerically pure aldehyde. The diastereomeric ratios are then 
compared; if the racemic electrophile provided a preference for one diastereomer, and the 
ratio enantiopure electrophile is close to 50:50, the benzyllithium is configurationally 
stable on the time scale of electrophile quench. The primary disadvantage with this test is 
the fact that a chiral electrophile must be used. An example of this test is shown in 
Scheme 23.
36
 
 
 
 
 
 
 
Scheme 23. Hoffman test for 73. 
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 Beak has also developed a test for configurational stability, dubbed the “Poor Man’s 
Hoffman test”. It involves the use of a chiral ligand instead of a chiral electrophile. This 
test essentially determines which step of the reaction causes racemization without the 
presence of the chiral ligand, and which step provides improved enantioselectivities. This 
is then a means to distinguish if the benzyllithium is configurationally stable resulting 
from asymmetric deprotonation (Path D) or configurationally labile  resulting from 
asymmetric substitution (Path S), Scheme 24.
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Scheme 24. “Poor Man’s Hoffman test” example for 77. 
 
 Secondary benzyl carbamates are known to exhibit configurational stability, 
because of the coordination of oxygen to the lithium counter ion. Hoppe studied the 
stereochemical course of lithiation−substitution with configurationally stable tertiary 
benzylic organolithium 80, Scheme 25.
38
 The stereochemistry of the resulting products 
was determined by comparison to known compounds. In general, electrophiles with 
halide or cyanide leaving groups led to inversion of stereochemistry, whereas 
25 
 
electrophiles with leaving groups capable of coordinating led to retention of 
stereochemistry. 
 
Scheme 25. Electrophile scope and resulting stereochemistry of 80a-f. 
 
Analogous to 80, indanylcarbamate 81 was synthesized and found to follow similar 
reaction profiles but with a greater affinity to retentive substitution; only chlorostannanes 
and CS2 electrophiles furnished inversion products, Scheme 26. Hoppe investigated this 
computationally, using the program MOPAC98, and determined that 80 is more planar 
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than 81. This planarity translates to 81 requiring over 40 kJ mol
−1
 more energy than the 
acyclic 80 to form the planar transition state necessary to form inversion products.
39
 
 
Scheme 26. Electrophile scope and resulting products’stereochemistry for 81a-f. 
 
Benzylic stannanes have been documented to undergo transmetalation with 
retention of stereochemistry. This transformation provides a means to access both 
stereoisomers in a synthesis. Beak studied the asymmetric benzylic lithiation of 
N−Boc−N−(p-methoxyphenyl) benzyl amine 82. It was determined that 82 forms a 
configurationally stable lithiated intermediate 83 that upon direct electrophile quench to 
provide (S) configured products. Transmetalation of the trimethyl−stannane adduct int-84 
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followed by electrophile quench provided access to the (R) configured product in high 
enantiomeric purity and yield, Scheme 27.
33b
 
 
 
 
 
 
 
 
 
Scheme 27. Transmetalation and direct quench reactions for 82. 
Remotely located directing groups, such as ethers, carbamates or amides, can 
allow for intramolecular coordination to give a cyclic intermediate complex, Scheme 
28.
40
 Ether 85a required a warm−cool cycle to afford products with good enantiomeric 
ratios. If the experiment was conducted at −78 °C, an enantiomeric ratio of 72:28 was 
obtained; amide 85b did not show an increase in enantioselectivity under the same 
conditions. Enantiomerically enriched tin derivatives were used to probe the 
configurational stability. When lithiation was attempted in the absence of (−)−sparteine, 
only racemic product was isolated. However, when either (−)−sparteine or (+)−sparteine 
surrogate were used, an identical level in enantiopurity was observed in the product. This 
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result suggested that the reaction likely operated as a dynamic thermodynamic resolution 
for ether 85a, but I an indeterminate mechanism for amide 85b.  
 
Scheme 28.  Amide and ether lateral lithiation directing groups. 
 
2.5 Rhodium hydroformylation 
The industrial process that converts alkenes to aldehydes employs transition metal 
catalysts, carbon monoxide and hydrogen gas.
41
  This is an atom−economical process, 
and is particularly useful because aldehydes are versatile chemical intermediates.
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Cobalt catalysts were initially used industrially for hydroformylation, but rhodium 
catalysts have become a mainstay as a result of their higher activity.
42b
  The mechanism 
of cobalt mediated hydroformylation was investigated by Heck and Breslow in 1961.
43
 
The rhodium mediated cycle has also been studied, and is shown below in Scheme 29. 
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The rhodium precatalyst is first converted to 16 electron fragment 87. This species then 
coordinates with the alkene to form an 18 electron, five−coordinate intermediate, 88. 
Migratory insert of the olefin can produce two four−coordinate intermediates, one leading 
to a branched aldehyde, (89a) and one leading to a linear aldehyde (89b). Coordination of 
another CO molecule into the vacant coordination site produces 90a or 90b. A migratory 
insertion of CO inserts into the alkyl ligand providing Rh−acyl intermediate 91a or 91b. 
Hydrogenolysis releases the aldehyde, and regenerates the active catalyst 87.
41, 44
 
Chemoselectivity is important in these reactions, as hydrogenation and alkene 
isomerization can also occur with rhodium catalysts. These side reactions are often 
minimized or prevented in hydroformylation, through the careful choice of phosphine, 
phosphite or hybrid ligands. 
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Scheme 29. Catalytic cycle for asymmetric rhodium catalyzed hydroformylation. 
 
Regioselectivity varies from substrate to substrate in most cases, and is dependent 
on both the directing ability of the substrate’s functional groups, and their interaction 
with the catalyst. This directing group effect was studied by Breit. For example,  
1−butene yields only linear aldehyde, but 4−(diphenylphosphino)−1−butene favours a 
branched aldehyde resulting from the intermediate 5−membered rhodacycle.44 Breit and 
coworkers also developed a catalytic phosphinite directing group for the 
hydroformylation of homoallylic alcohols, in order to access branched aldehydes 
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(Scheme 30).
45
 This constituted another excellent example of how a directing group can 
overcome inherent substrate bias, as homoallylic alcohols typically provide linear 
aldehydes. 
 
Scheme 30. Catalytic cycle for asymmetric hydroformylation of homoallylic alcohols. 
 
Regioselectivity can also be changed by modifying the catalyst. Bidentate phosphine 
ligands were shown by Casey to affect the ratio of branched to linear products based on 
which chelate is formed.
46
 For bisphosphines, diequatorial and equatorial−axial chelates 
exist. The bite angle of the phosphine, defined as the ligand-metal-ligand angle of a 
bidentate ligand, determines which of these chelates is formed.
47
 The chelate directs the 
migratory insertion of the olefin to the Rh−H bond, which determines whether a branched 
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or linear aldehyde will be produced. Large bite angles of approximately 120° result in 
axial−equatorial chelates to give linear products, whereas small bite angles of 
approximately 90° shift the ratio slightly more towards the branched products, Figure 
5.
46
 Vinyl arenes tend to favour branched aldehyde formation, while alkyl olefins tend to 
favour linear aldehyde formation. The production of solely linear aldehydes is essentially 
a solved problem, as a result of extensive research into phosphine ligands.  
 
 
 
 
Figure 5. Relationship between bite angle and chelate geometry. 
 
The lack of simultaneous control of both regio− and stereoselectivity has likely 
limited the use of enantioselective hydroformylation in the manufacturing of fine 
chemicals. The greatest efforts have focused on vinyl arenes, the resulting aldehydes of 
which can be easily transformed into 2−aryl propionic acids, which are a class of 
non−steroidal drugs.48 More recent efforts have begun to include other substrates, such as 
vinyl acetate, unsaturated nitriles, and heterocyclic compounds, as the resulting aldehydes 
provide a versatile handle for subsequent chemistry. The early days of enantioselective 
hydroformylation included attempts with platinum and tin catalysts, which suffered from 
poor regio− and enantio−selectivity, as well as hydrogenation as a side reaction.49 The 
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next development was the Rh−DIOP catalyst, which suffered both a slow reaction rate, 
and low enantioselectivity.
50
 A real breakthrough occurred in 1992, when Babin and 
Whiteker developed the diphosphite ligand Chiraphite® for styrene hydroformylation, 
Scheme 31. 
51
The diequatorial orientation is crucial for the high enantioselectivity 
observed.
52
 The bulky substituents at the ortho positions of the biphenyl rings were 
determined to be necessary for both regio− and enantioselectivity, while the p−methoxy 
groups were superior to the t−butyl groups in all cases for better enantioselectivity. 
Several other research groups engaged in modifications of Chiraphite, including studies 
on bridge length, phosphite moieties, and the cooperative effect of multiple chiral 
centres.
53
 These studies showed that three−carbon bridges provided superior 
enantioselectivity over two− and four−carbon bridges. Sterically hindered phosphite 
groups were also necessary to maintain high enantioselectivity. These diphosphite ligands 
provided good to excellent enantioselectivity for allyl cyanide and vinyl acetate, but poor 
enantioselectivity for styrenes.  
 
 
 
 
 
 
Scheme 31. Asymmetric hydroformylation of styrene using Chiraphite®. 
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Bisphosphines have also been utilized in asymmetric hydroformylation. The [(R, 
R)−Ph−bpe]−103 ligand is universal for allyl cyanide, styrene and vinyl acetate. The 
process requires high temperatures and suffers from low to moderate conversions. 
However it provides moderate to excellent regioselectivity, and excellent 
stereoselectivity, Scheme 32.
54
 Chiral diazaphospholane 105, synthesized and tested by 
Landis et al., 
55
  displayed excellent enantioselectivity for vinyl acetate, a more 
challenging substrate, as well as high enantioselectivities for styrene and allyl cyanide 
(Scheme 32). Nonetheless, hydroformylation using 105 suffered from lower 
regioselectivity than utilizing Klosin’s bisphosphine 103. 54 
 
 
 
 
 
 
 
 
 
 
Scheme 32. Asymmetric hydroformylation with bisphosphine ligand 103. 
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Scheme 33. Asymmetric hydroformylation with diazaphospholane 105. 
 
Hybrid ligands, which take advantage of the best of both components of the 
preceding reactions, tend to be the best ligands for asymmetric hydroformylation. One of 
the first successful hybrids was (R, S)−BINAPHOS−106 by Takaya and coworkers, 
Figure 6.
56
The ligand comes a phosphine BINAP component plus a phosphite. Active 
catalysts containing ligand 106 gave (R)-104a in 92 % ee. Hydroformylation using (S, 
R)−BINAPHOS−107 provided (S)-104a  in 94% ee. The most effective ligand used for 
the hydroformylation of styrene is YanPhos−108, a phosphite−phosphoramidite analogue 
of BINAPHOS.
57
 It provides full conversion of styrene to (R)-104a with an 88:12 
branched to linear ratio, in 98% ee.
56-57
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Vinyl arenes are the most studied substrates in hydroformylation, with a variety of 
established catalysts. Alkyl olefins are more problematic, as the inherent bias in these 
substrates favours the linear regioisomer. This bias leads to only good regio− or 
enantioselectivity being achieved. Cobley and Clarke synthesized 
(Sax,S,S)−Bobphos−109, which is a hybrid of Kelliphite and Ph−bpe,
58
 Excellent 
enantioselectivities were observed, and worthy of mention is the results for n−heptene, 
for which moderate regio− and enantioselectivity were observed, Scheme 34.58  
 
 
 
 
 
 
 
 
 
Figure 6. Examples of hybrid phosphorus ligands for asymmetric hydroformylation. 
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Scheme 34. Asymmetric hydroformylation using hybrid ligand (Sax,S,S)−Bobphos−109. 
 
More recently, a hybrid of Landis’ diazaphospholate−105 and YanPhos−108 was 
synthesized in collaboration with Zhang and Wang, 112. Studies demonstrated that this 
ligand allows for a wide substrate scope, from styrene derivatives, vinyl esters, to 
substituted allyl substrates (Table 1).
59
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R b:l ee Conversion (%)
H 24:1 85 99
4-Me 20:1 80 98
4-OMe 20:1 77 93
4-F 19:1 83 99
2-F 58:1 88 99
Me 53:1 91 99
tBu 24:1 91 99
nC7H15 45:1 93 87
nC9H19 34:1 93 85
Ph 240:1 91 80
TMSO 2.4:1 94 99
TBSO 2:1 83 99
PhO 3:1 90 99
AcO 3:1 92 67
TMS 0.5:1 91 83
Ph 1.1:1 90 99 
 
Table 1. Substrate scope for hybrid ligand 112. 
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An underexplored area of rhodium−mediated hydroformylation is the application 
of N−heterocyclic carbene ligands. N−heterocyclic carbene ligands are similar in nature 
and reactivity to phosphines, however there are few literature examples of Rh−NHC 
complexes used for hydroformylation, and to date, only one asymmetric example. The 
first successful Rh−NHC hydroformylation catalysts were reported by Crudden  in 2000, 
Scheme 35 and Scheme 36.
60
 Two catalysts were synthesized and studied, 113 and 116. 
Both 113 and 116 were found to provide excellent yields, and excellent branched to 
linear ratios for styrene derivatives. Later, in 2003, Peris and coworkers published their 
research on a dimetallic Rh−NHC hydroformylation catalyst, 117.61 Excellent 
conversions and high branched aldehyde yields were reported for styrene derivatives, as 
well as moderate conversions for 1−octene, a more difficult substrate, Scheme 37. 61  
 
 
 
 
 
 
 
Scheme 35. Hydroformylation studies for Rh−NHC complex 113. 
 
Ar b:l Yield (%)
Ph 96:4 85
p-MePh 96:4 86
p-ClPh 97:3 94
p-MeOPh 95:5 98
p-iBuPh 96:4 93
40 
 
 
 
 
 
 
 
 
Scheme 36. Hydroformylation studies for Rh−NHC complex 116. 
 
 
 
 
 
 
 
 
Scheme 37. Hydroformylation scope for Rh−NHC complex 117. 
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The underexplored area of Rh−NHC hydroformylation catalysis has one reported 
asymmetric hydroformylation, by Lai and coworkers, Scheme 38. Only slight 
enantioselectivity was observed, with a low branched to linear ratio. 
 
 
 
 
 
  
Scheme 38. Asymmetric Rhodium Hydroformylation with rhodium complex 118. 
3. Aims and Objectives 
 
The first project of this research was to expand the scope of the L−proline derived 
chiral auxiliary beyond ferrocenes to diastereoselective lithiation of an N-benzyl 
substrate. The lack of known chiral directing groups for benzylic prochiral substrates 
made this an area of interest. Our initial approach to this research was to substitute the 
accessible nitrogen of L-proline hydantoin with allyl or benzyl substituents, and then 
reduce the corresponding N−substituted hydantoin to the corresponding aminal, which 
could be protected in situ analogous to the ferrocene chemistry, providing a single 
diastereomer for asymmetric lithiation, Scheme 39. Attempts towards asymmetric 
lithiation should include screening of conditions, including solvents, bases, diamine 
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additives, and chiral diamine additives for match−mismatch pair interactions, 
transmetalation, and a variety of electrophiles. The goal of these various reactions being: 
1. To determine if the chiral auxiliary is capable of inducing asymmetric 
lithiation−substitution reactions. 
2. To determine if the stereoselectivity arises from asymmetric deprotonation, or 
asymmetric substitution. 
3. To obtain products with high diastereomeric purity, that can then be used as 
ligand precursors for asymmetric catalysis. 
 
 
 
 
 
 
Scheme 39. Proposed synthetic route to chiral auxiliary 120 and asymmetric 
lithiation−substitution products 121. 
 
The second project in this thesis was inspired by the lack of an asymmetric Rh−NHC 
catalyst, and  good conversions and moderate enantioselectivity observed using Ir catalyst 
68 in asymmetric hydrogenation of quinolone, which prompted us to explore the potential 
of 65 ligand precursor in asymmetric rhodium hydroformylation. The rhodium carbonyl 
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complex 123 had been previously synthesized our group, and was waiting for an 
application in catalysis, Scheme 40. Our initial approach was to use a test substrate, and 
scan for best conditions, before expanding the substrate scope if positive results were 
obtained. 
 
Scheme 40. Synthetic route to Rh−NHC−dicarbonyl complex 123. 
4. Results and Discussion 
4.1 Preparation and diastereoselective lithiation of (1R,7aS)− 2−benzyl− 
1−((triethylsilyl)oxy)tetrahydro−1H−pyrrolo[1,2−c]imidazol−3(2H)−one (120)  
 
Preparation of 119 was first attempted by refluxing 48 in acetonitrile with 
potassium carbonate and benzyl chloride. This procedure did result in N-benzylation, but 
also led to partial racemization of the stereocentre derived from L-proline. Racemization 
was avoided by using a substoichiometric amount of sodium hydride in DMF, followed 
by addition of benzyl chloride. This method furnished the desired product without 
racemization, in a 64% yield after recrystallization, Scheme 41. Hydantoin 119 was then 
reduced with Schwartz reagent, and the resulting aminal protected in situ with 
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chlorotriethylsilane, to provide 120, shown to be syn and a single diastereomer by 
1
H 
NMR (Scheme 40). 
 
 
 
 
 
Scheme 41. Synthetic route to 120. 
 
The first set of lithiation screenings utilized BuLi/TMEDA as the base, and 
TMSCl as the electrophile. The screenings included three bases (sec−butyllithium, 
n−butyllithium, and tert−butyl lithium) and four common lithiation solvents (diethyl 
ether, THF, toluene, and hexanes).The best diastereomeric ratio was 7:1, obtained in 
toluene with n−butyllithium. The diastereomeric ratios were determined by 1H NMR. A 
test reaction in the absence of TMEDA resulted in no stereoselectivity− a 1:1 dr was 
observed (Scheme 41).  
45 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 42. Reaction screenings for base, additive and solvent for the asymmetric 
lithiation−substitution of 120. 
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After screening of solvents, bases, and additive choices, electrophile scope was explored, 
Scheme 43. The alkyl stannane derivatives 121b and 121c both provided a high dr of 
10:1.      
 
 
 
 
 
 
 
 
 
Scheme 43. Electrophile scope for the diastereoselective lithiation−substitution of 120. 
 
Transmetalation of 121b to 121a provided the same major diastereomer as the direct 
quench with trimethylsilyl chloride, but with a 10:1 diastereomeric ratio instead of 7:1, 
Scheme 43. In the absence of TMEDA, no transmetalation occurred. Transmetalation of 
121c and quench with methyl iodide provided the same major diastereomer as in the 
direct quench, and with the same diastereomeric ratio. The transmetalation of 121c to 
121g provided the same major diastereomer with the same diastereomeric ratio as 121c.  
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Scheme 44.  Transmetalation reactions of N−benzyl stannanes 121b and 121c. 
 
The same major diastereomer is obtained for TMS, Me, and Ph2COH adducts 
from both direct quench and transmetalation. Additionally, both dimethyl sulphate and 
methyl iodide provided the same major diastereomer, but the dimethyl sulphate gave 
higher diastereomeric ratio. The transmetalation results demonstrate that the benzylic 
carbanion has sufficient configurational stability such that the products retain 
stereochemistry of the original stannane. The two syn stereocentres in 120 are likely to 
leave the anti benzylic proton most readily available for deprotonation. Additionally, this 
would allow coordination between the lithium base and the carbonyl oxygen, which 
would act to stabilize the resulting benzyllithium.  The major diastereomer from 
benzophenone quench 121g was recrystallized to obtain x−ray quality crystals. X−ray 
diffraction of 121g revealed the anti stereochemistry, Figure 7. Combined with the 
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transmetalation results, which demonstrate all products have the same relative 
stereochemistry, it can be concluded that all products 121a−g are anti.  
 
Figure 7. Crystal structure of anti−121g (major diastereomer). 
 
 The transmetalation results for 121c to 121g and 121b to 121a showed retention 
of the starting stannane stereochemical purity in the product. For product 121a this led to 
an improved diastereomeric ratio, and for 121g this led to a slightly diminished 
diastereomeric ratio, when compared to the diastereomeric ratio obtained from direct 
quench (Scheme 44). These results suggested that the asymmetry may be arising during 
the deprotonation, but this required further study to validate. Investigating whether an 
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asymmetric deprotonation or asymmetric substitution is occurring is more challenging in 
diastereoselective lithiation because the pre−existing chirality of the substrate dictates the 
selectivity, and cannot be “hidden” from either deprotonation or substitution to determine 
the stereodetermining step.  In enantioselective lithiation, the Hoffman test, or variations 
(such as “Poor Man’s Hoffman tests”) discussed previously (Scheme 24 and 25) can be 
easily done to determine the step which requires the chiral ligand, and is therefore the 
stereoselective step.  
There is no analogous test for a diastereoselective case, but by utilizing a chiral ligand in 
place of TMEDA, a “match−mismatch” pair interaction can occur. A “match−mismatch” 
pair interaction involves the interaction between the configuration of the substrate and the 
configuration of the ligand, and depending on the diastereomer of the chiral ligand, it can 
“match” and improve the stereoselectivity of the reaction, or “mismatch” and cause an 
erosion of stereoselectivity. Attempts were therefore made to try and induce a 
match−mismatch pair interaction to both improve the diastereomeric ratios, and provide 
more insight into the reaction pathway. The results of match-mismatch pair attempts are 
summarized in Scheme 45. The low yields and 1:1 diastereomeric ratios obtained suggest 
that the resulting chiral base was too bulky to effectively deprotonate, leading to a low 
yield, and cannot discern between the two prochiral benzylic hydrogens. 
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Scheme 45. Match-mismatch pair attempts with chiral cyclohexyl diamine ligands (R,R)-
32 and  (S,S)-32. 
 
 Deuteration studies were then carried out to see if there would be an observable 
kinetic isotope effect (KIE), which would result in an erosion of the diastereomeric ratio, 
implicating the deprotonation as the stereoselective step, Scheme 46. The deuterated 
product 120-d was obtained in 8:1 dr, and subject to lithiation-substitution under the 
standard lithiation conditions. The resulting ratio for 121g obtained from deuterated 120-
d was significantly diminished in comparison to undeuterated 120, but the same major 
diastereomer was obtained, Scheme 47. The regions of interest for comparison in the 
1
H 
NMR for these studies are shown in Figure 8 and 9. The benzylic doublets disappear in 
the deuterated 120-d spectrum, showing excellent deuterium incorporation. Figure 9 
shows the spectra for 121g obtained from undeuterated 120 and deuterated 120-d. 
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Scheme 46. Deuteration of  120. 
 
 
Scheme 47. Lithiation-substitution of 120-d to benzophenone adduct 121g. 
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Figure 8. 
1
H NMR spectra expansions of undeuterated 120 (top) and deuterated 120-d 
(bottom). 
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Figure 9. 
1
H NMR spectra expansions for 121g derived from undeuterated 120 (top) and 
deuterated 120-d (bottom). 
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 It can be observed that the same methine doublet is the major peak, so the same major 
diastereomer is produced in both cases, but the deuterated starting material results in a 
diminishment of the diastereomeric ratio.  This means there is a KIE, resulting from the 
anti proton being preferentially removed, and since abstraction of deuterium is slower 
than hydrogen, this leads to a diminished diastereomeric ratio, and a major diastereomer 
with no deuterium incorporation. This result is in agreement with the transmetalation 
results, and together, suggests that that the stereoselectivity arises from an asymmetric 
deprotonation. In attempt to quantify the KIE, a second experiment was completed, in 
which 120-d was subject to lithiation again, and quenched with methanol, Scheme 48. 
The ratio of deuterated to undeuterated products from the 
1
H NMR could then be 
measured and from this ratio a relative KIE could be obtained. After completing the 
experiment, the KIE could not be obtained due to extensive overlap of peaks in the 
1
H 
NMR leading to an inaccurate product ratio.  
 
Scheme 48. Lithiation and quench attempt to quantify the Kinetic Isotope Effect. 
 
Additionally, in pursuit of further application as a ligand precursor, 120g was cyclized 
with catalytic p-toluene sulfonic acid in chloroform, providing annulated urea 123, 
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Scheme 49. Analogous to ferrocenyl annulated urea 64, this urea may be a useful ligand 
precursor for asymmetric catalysis. 
 
 
 
Scheme 49.  Cyclization of 121g to annulated urea 124. 
 
4.2 Rhodium hydroformylation with (–)−2−[2Sp−(5,5−Diphenyl−ferrocenyl] 
(6aS,6bS)−6a,6b,7,8,9,11−hexahydro−5H pyrrolo−[1',2':3,4]imidazol−2−ylidene) 
diformylrhodium(IV) chloride (123) 
The rhodium carbonyl complex 123 was previously synthesized in the Metallinos group 
as a means to measure the donating ability of the N-heterocyclic carbene (NHC)  ligand, 
by comparison to other Rh-NHC carbonyl complexes.
62
 The wavenumber of the CO 
stretching frequency is inversely proportional to the degree of σ−donation from the NHC 
ligand, Figure 10.   
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Figure 10. Donor capacity of selected NHC ligands demonstrated by RhCl(CO)2L 
complex CO stretching frequency. 
 
With the synthetic route already in hand, trial hydroformylation reactions were begun 
using allyl benzene as the test substrate. A moderate syngas (1:1 CO:H2) pressure of 20 
bar, and slightly elevated temperature of 60 °C  were chosen. These conditions were 
picked to push conversion of starting material, without being too harsh and eliminating 
any possibility of stereoselectivity, which has been shown to be dependent on 
temperature. Since NHCs behave similiarly to phosphines, one experiment was 
performed with no additional phosphorus−containing ligand. Several phosphites and two 
phosphines were also chosen for screening. To minimize the possibility for racemization 
of the chiral aldehydes, the crude reaction residues were immediately reduced with 
sodium borohydride in ethanol to their corresponding alcohols. The ratio of branched to 
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linear alcohols and the ratio of S and R alcohols were determined by HPLC analysis with 
a chiral OD−H column. Without the addition of a phosphorus−containing ligand, poor 
conversion was observed, and confirmed with a low isolated total alcohol yield of 14 %, 
Scheme 50. This experiment also had a poor branched to linear ratio of 1:5. The addition 
of phosphite ligands provided good conversion, with a moderate favouring for the 
branched aldehyde product. The use of added phosphine ligands favoured linear aldehyde 
formation in both cases. Unfortunately, in all cases, the branched alcohol was racemic, 
Scheme 50. 
 
 
 
 
 
 
 
 
 
 
Scheme 50. Hydroformylation screening of 123 and reduction of the resulting aldehydes 
to their corresponding alcohols 126. 
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In order to help determine if the racemization was a result of poor catalyst selectivity or 
racemization of the resulting aldehydes before reduction, aliquots were removed as the 
reaction proceeded, and immediately subjected to reduction. The first time point, and 
both aliquots thereafter, were all found to contain only racemic branched alcohol. Most 
asymmetric hydroformylation reactions utilize chiral phosphorus containing ligands, in 
conjunction with Rh(acac)(CO)2. The next investigation therefore utilized this as the 
rhodium source, along with ylidene 127 generated in situ by reaction of 66 with KOtBu, 
and Rh(acac)(CO)2 in a sealed tube. The resulting mixture was then transferred with a 
cannula to a vial containing allyl benzene, and triphenyl phosphite. The reaction mixture 
was the subject to the same hydroformylation conditions as catalyst 123. Once again, the 
resulting aldehydes were immediately converted to their corresponding alcohols, and the 
regio− and stereoselectivity of the hydroformylation was determined from chiral HPLC 
analysis. A 1:1 b:l ratio was obtained with a moderate isolated alcohol yield of 63%, and 
a low enantiomeric ratio of 57.5:42.5 (R: S), Scheme 51. Although an improvement from 
the original catalyst 123, this result was not promising enough to warrant further 
research.  
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Scheme 51. Hydroformylation reaction with Rh(acac)(CO)2, ylidene 127 and P(OPh)3. 
5. Conclusions and Future Work 
In the first project, the scope of a chiral directing group derived from L-proline 
was expanded to diastereoselective benzylic lithiation-substitution with up to 11:1 dr. The 
starting material 120 was derived from N-benzylation of L-proline hydantoin, followed 
by stepwise stereoselective hydrosilylation. Transmetalation experiments corroborate 
with x−ray diffraction data of the benzophenone adduct 121g, providing the absolute 
stereochemistry of all products 121a-g. 
In the second project, rhodium complex 123 was able to act as a catalyst for the 
hydroformylation of allyl benzene, resulting in a ratio of 3:1 branched to linear products, 
but no stereoselectivity was observed. The use of ylidene 127 in conjunction with 
Rh(acac)(CO)2 and triphenyl phosphite resulted in a 1:1 ratio of branched to linear 
products, with the branched alcohol resulting in a low enantioselectivity of 57.5: 42.5, 
favouring the R enantiomer.  
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Future work will include attempts towards the formation of telluride derivatives 
of 120. Similar in reactivity to stannane derivatives, it is hoped telluride derivative, 
Scheme 52, would be crystalline allowing for isolation of a diastereomerically pure 
intermediate for transmetalation. Alternatively, transmetalation to another metal, such as 
a magnesiate or zincate intermediate may provide a more configurationally stable 
intermediate that would provide a single diastereomer. Conversion of the urea to an 
ylidene would then provide access to a potential bidentate ligand for asymmetric 
catalysis. Other electrophiles will also be explored, such as bulky chlorophosphines, 
which may provide greater diastereoselectivity and crystallinity, without the need for 
transmetalation.  
 
 
 
 
 
Scheme 52. Proposed tellurium derivative for transmetalation and catalyst applications. 
 
Analogous to annulated ferrocenyl urea anti-64, 124 will be investigated as a 
ligand precursor for transition metal complexes, for potential application in asymmetric 
catalysis, Scheme 53. 
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Scheme 53. Proposed ligand synthesis from urea 124. 
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6. Experimental Procedures 
General Experimental. 
All reagents were purchased from Aldrich, Fisher Scientific, Acros, Strem or Oakwood 
chemicals and used as received unless otherwise indicated. Tetrahydrofuran and diethyl 
ether were freshly distilled from sodium/benzophenone ketyl under an atmosphere of 
nitrogen. Toluene was freshly distilled from sodium under an atmosphere of nitrogen. 
Dichloromethane and dimethyl sulfoxide were distilled from CaH2 under an atmosphere 
of nitrogen. Syngas (1:1 CO: H2) was obtained from Praxair. All alkyllithium and lithium 
amide bases were titrated against N-benzylbenzamide to a blue endpoint.
63
 All reactions 
were performed under nitrogen in flame-or oven-dried glassware using syringe-septum 
cap techniques unless otherwise indicated. TLC was performed on silica gel. Column 
chromatography was performed on silica gel 60 (70-230 mesh). Schwartz’s reagent was 
prepared according to a literature procedure.
64
 NMR spectra were obtained on a Bruker 
Avance 300, 400 or 600 MHz instrument and are referenced to the residual proton signal 
of the deuterated solvent for 1H spectra, and to the carbon multiplet of the deuterated 
solvent for 13C spectra according to published values.
65
  FT-IR spectra were obtained on 
Bruker ALPHA platinum ATR spectrometer as neat material. Optical rotations were 
measured on a Rudolph Research Autopol III automatic polarimeter. Mass spectra were 
obtained on a Micromass GCT spectrometer.Combustion analyses were performed by 
Atlantic Microlab Inc., Norcross, GA, USA. Melting points were determined on a Kofler 
hot-stage apparatus and are uncorrected. 
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L−proline hydantoin (48)66. 
To a solution of L−proline (50.0 g, 0.43 mol)  in distilled water (150 mL) 
was added solid potassium cyanate (42.0 g, 0.52 mol) and the reaction 
mixture was heated at reflux for 1 hour. After cooling to room temperature, 
6 M hydrochloric acid (150 mL) was added dropwise from an addition funnel. The 
reaction mixture was brought to reflux for an additional two hours. The reaction mixture 
was cooled to room temperature and transferred to a refrigerator (4 °C) overnight to 
crystallize the product. The resulting white needles  were collected by vacuum filtration, 
washed with water, and recrystallized from hot MeOH/water to give 48 (24.38 g, 40 %); 
mp 172−174 °C (MeOH/water) [lit mp 163−165 °C (water)]; [α]D
20
 −137 (c 1.0, MeOH) 
[ lit[α]D
20 −150 (c 1.0, MeOH)]66 IR (solid, ATR) νmax 3171, 3062, 2734, 1701, 1297, 
1023 cm
−1
. 
Iodoferrocene (58)
67
. 
The title compound was prepared by adapting a literature procedure for the 
synthesis of formyl ferrocene;
68
  to a three−neck round bottom flask, 
ferrocene (20.0 g, 0.108 mol) and potassium t−butoxide (1.45 g, 0.0129 mol)  were 
added, followed by THF (1 L). The reaction mixture was cooled to −75 °C in a dry 
ice/acetone bath. A solution of t−BuLi in pentane (203 mL, 1.06 M, 0.215 mol) added 
drop−wise, ensuring that the internal temperature did not rise above −70 °C, monitored 
through the use of an internal thermometer. Following addition of t−BuLi, the reaction 
mixture was stirred for 1 hour at −70 °C. Iodine (63 g, 0.247 mol) was added in a single 
portion to the reaction mixture under a heavy flow of nitrogen. The reaction mixture was 
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kept at an internal temperature of −40 °C for 20 minutes, before warming to −30 °C. The 
reaction mixture was quenched with water, diluted with diethyl ether, and washed with 
saturated Na2S2O3. The organic layer was dried over Na2SO4, filtered, and concentrated 
under reduced pressure. The resulting crude residue was dissolved in hexane, filtered 
through a pad of silica gel, and concentrated under reduced pressure providing a 
brown−orange oil (19.20 g, 57%) that solidified upon standing; mp 38−39 °C  (hexane); 
[lit mp 43−45 °C (petroleum ether)].67 1H NMR (300 MHz, CDCl3) δ 4.20 (s, 5 H), 4.17 
(s, 4 H); 
13
C NMR (75 MHz, CDCl3) δ 74.4, 71.0, 68.8, 67.9.  
(−)−2−Ferrocenyl−7aS−tetrahedropyrrolo[1,2−c]imidazole−1,3−dione (59) 31. 
       A mixture of iodoferrocene (10.24 g, 0.03 mol), L−proline 
hydantoin (7.86 g, 0.06 mol), and cuprous oxide (4.25 g, 0.03 mol) 
in DMSO (30 mL) was placed in an oven−dried round bottom flask 
with stirring bar under argon and heated at 120 °C for 43 hours. After cooling to room 
temperature, the reaction mixture was diluted with diethyl ether, and filtered through a 
pad of Celite. The resulting filtrate was then washed with water (6 ×), dried over Na2SO4, 
filtered and concentrated under reduced pressure. Flash column chromatography (silica 
gel, 7:3 hexane/EtOAc, Rf = 0.22) provided 59 as an orange solid, which was 
recrystallized (CH2Cl2/hexane) to give 59 (5.20 g, 49 %) as brown−orange blocks; mp 
111−112 °C (CH2Cl2/hexane) [literature mp 112−113 °C (CH2Cl2/hexane)
31
;  [α]D
20
 −123 
(c 0.9, CHCl3) [ literature [α]D
20 
 −128 (c 1.09, CHCl3 )
31
; IR (solid, ATR) νmax 3129, 
3087, 2973, 2904, 1769, 1706, 1484, 1388, 1372 cm
−1
.  
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(+)−2−Ferrocenyl−1R−triethylsilyoxy−7aS−hexahydropyrrolo[1,2−c]imidazole−3 
−one (61)31. 
Hydantoin 59 (5.02 g, 0.015 mol) and Schwartz’s reagent (5.18g, 
0.02 mol) were suspended in THF (140 mL). The reaction mixture 
was stirred at room temperature for 10 minutes, before turning into a 
homogenous solution, indicating consumption of starting material. Imidazole (2.41 g, 
0.035 mol) and DMAP (172 mg, 1.41 mmol) were added as solids by rapid removal and 
replacement of the septum, followed by TESCl (3.9 mL, 0.02 mol) which was added by 
syringe. The reaction mixture was stirred at room temperature for an additional 5 hours, 
before work up with water, and dilution with diethyl ether. The organic phase was 
washed with 10% CuSO4 solution (2×), saturated NaHCO3, and water. The resulting tan 
precipitate was filtered off by passing the organic layer through a pad of Celite. The 
solution was dried over Na2SO4, filtered, and concentrated under reduced pressure. 
Purification by flash column chromatography (silica gel, 7:3 hexane/EtOAc, Rf = 0.42), 
and recrystallization (EtOH/water) provided 61 as an orange crystalline solid (3.38 g, 
49%); mp 96−98 °C [literature mp 97−98 °C]31; [α]D
20 
 +120 (c 1.0, CHCl3) [literature 
[α]D
20 
 +111 (c 1.0, CHCl3)]
31
; IR (solid, ATR) νmax 3084, 2951, 2875, 1686, 1496, 1407, 
1080, 1001 cm
−1
.  
(+)−2−[2Sp−(Diphenylhydroxymethyl)ferrocenyl]−1R−triethylsilyloxy−7aS 
hexahydropyrrolo[1,2−c]imidazole−3−one (62g)31. 
To a flame−dried, argon−purged flask, 61 (2.03 g, mol) was added, 
and dissolved in THF (55 mL). After cooling to −78 °C, a solution 
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of t−BuLi in pentane (9.2 mL, 1.10 M, 10.15 mmol) was added dropwise. After stirring 
for 30 minutes at −78 °C, a colour change from orange to orange−red was observed. A 
solution of benzophenone (2.10 g, 0.012 mol) in THF (15 mL) was added to the solution 
by slow cannulation, causing an immediate colour change from red−orange to 
blue−green. The resulting reaction mixture was stirred for an additional 30 minutes at 
−78 °C before work up with water. After warming to room temperature, the reaction 
mixture was diluted with diethyl ether. The organic phase was washed with water, then 
brine, dried over Na2SO4, filtered, and concentrated under reduced pressure. The crude 
orange residue was purified by flash column chromatography (silica gel, 8:2 
hexane/EtOAc, Rf = 0.40) gave 62g as an orange solid (2.19 g, 76 %); mp 66−67 °C 
[literature mp 65−66 °C]31; [α]D
20
 +141 (c 0.73 CHCl3) [literature [α]D
20
 +137 ( c 0.67 
CHCl3)]
31
; IR(solid, ATR) νmax 3227, 2954, 2875, 1681, 1466, 1407 cm
−1
.  
(+)−(1S,7aS)−1−(benzhydryloxy)−2−ferrocenyl−tetrahydro−1H−pyrrolo[1,2−c]imid
azol−3(2H)−one (64) 32. 
A solution of 62g (1.41 g, 2.20 mmol) and p−toluene sulfonic acid 
(864 mg, 4.54 mmol) in CHCl3 was stirred at room temperature for 5 
minutes, turning from orange to dark brown. The reaction mixture 
was quenched with saturated NaHCO3, and the aqueous layer extracted with CH2Cl2. The 
combined organic layer was dried over Na2SO4, filtered and concentrated under reduced 
pressure. The brown crude residue was dissolved in CH2Cl2, and hexane was added 
dropwise until anti-64g precipitated out of solution as an orange powdery solid (646 mg, 
58%); mp >230 °C (CH2Cl2/hexane) [literature mp 251−252 °C (CH2Cl2/hexane)]
32
; 
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[α]D
20
 +170 ( c 0.5 CHCl3) [literature [α]D
20
 +168 ( c 0.5, CHCl3)]
32
; IR (solid, ATR) νmax 
3085, 2950, 1704, 1599, 1491, 1409 cm
−1
. 
(+)−(1S,7aS)−1−(Benzhydryloxy)−2−ferrocenyl−hexahydro−1H−pyrrolo[1,2−c] 
imidazole (65)
32
. 
A solution of anti−64 (314 mg, 0.64 mmol) in THF (40 mL) under 
argon was cooled to −78 °C, before dropwise addition of DIBAL 
(4.3 mL, 0.6 M, 2.56 mmol). The reaction mixture was allowed to 
warm slowly to room temperature over 16 hours, changing from orange to orange−red. 
The reaction mixture was quenched with Rochelle’s salt at 0 °C, diluted with diethyl 
ether and stirred for 1 hour until solid precipitate was observed. The resulting suspension 
was filtered through a pad of Celite, washing with diethyl ether. The combined organic 
layer was dried over Na2SO4, filtered and concentrated under reduced pressure. 
Purification with flash column chromatography (silica gel, 50:46:4 EtOAc/hexane/NEt3, 
Rf = 0.30) to yield 65 as an orange solid (256 mg, 84%); mp 203−205 °C (CH2Cl2) 
[literature mp 203−204 °C]32 ; [α]D
20
 +317 (c 0.5 CHCl3) [literature [α]D
20
 +312( c 0.5 
CHCl3)]
32
;  IR (solid, ATR) νmax 3087, 3023, 2923, 2828, 1600, 1469, 1409 cm
−1
.  
(−)−Chloro[η4−1,5−cyclooctadiene]2−[2Sp−5,5−diphenyl−ferrocenyl](6aS,6bS)−6a,6
b,7,8,9,11−hexahydro−5H− pyrrolo[1',2':3,4] imidazol−2−ylidene]rhodium (122).  
A solution of 65 (80.0 mg, 0.17 mmol) and tritylium 
tetrafluoroborate (55.0 mg, 0.17 mmol) in CH2Cl2 (2 mL) was 
stirred in a Schlenk flask, covered from light, at room 
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temperature. After 5 h, solvent was removed in vacuo and the crude solid was washed 
with dry diethyl ether (3 ×) and dried in vacuo. To this was added Rh(μ−Cl)(cod)]2 (41.0 
mg, 0.08 mmol) and degassed THF (6 mL) in a glovebox. The solution was cooled to –78 
°C and, with increased flow of nitrogen, KOtBu (19.0 mg, 0.17 mmol) was added at –78 
°C and the reaction mixture was allowed to warm to room temperature over 16 hours. 
The volatiles were removed under reduced pressure and purification of the residue by 
flash column chromatography (silica gel, 7:3  hexanes/EtOAc, Rf = 0.25) afforded 122 
(59 mg, 0.08 mmol, 49%) as orange crystalline solid; mp 181−184 °C; [α]D 
20
 –216 (c 
1.0, CHCl3); IR (KBr) νmax 2960, 2916, 2873, 2827, 1523, 1402, 1252 cm
–1
 ; 
1
H NMR 
(300 MHz, CDCl3) δ 7.67 (d, 2H, J = 7.5 Hz), 7.51 (t, 2H, J = 7.2 Hz), 7.42 (t, 1H, J = 
7.2 Hz ), 7.14−7.12 (m, 3H), 6.86−6.83 (m, 2H), 6.53 (s, 1H), 5.71 (d, 1H, J = 3.6 Hz), 
5.23−5.21 (m, 1H), 5.11−5.06 (m, 1H), 4.66−4.57 (m, 1H), 4.27 (s, 1H), 3.96 (m, 2H), 
3.81 (s, 5H), 3.67−3.56 (m, 2H), 3.20−3.15 (m, 1H), 2.48−2.17 (m, 5H), 1.99−1.97 (m, 
5H), 1.67−1.61 (m, 2H); 13C NMR (75.5 MHz, CDCl3) δ 212.7, 146.5, 144.9, 127.9, 
127.8, 127.7, 127.5, 126.2, 100.4, 99.9, 99.8, 88.9, 81.5, 70.9, 70.6, 68.7, 67.3, 67.1, 64.8, 
64.3, 62.1, 46.6, 33.1, 32.7, 29.1, 28.6, 28.4, 25.6; FABMS [m/z (%)] 810 (M+ , 2), 95 
(50), 91 (36), 67 (70), 55 (100), 43 (99), 39 (54), 29 (73); HRMS (FAB) calcd for 
C37H38N2OClFeRh: 720.1077; found 720.1023. Anal. calcd for C37H38N2OCl
56
FeRh: C, 
61.64; H, 5.31. Found: C, 61.06; H, 5.61. This discrepancy can be accounted for 
considering ethyl acetate as an impurity at 0.8%, which provides C: 61.01; H, 5.65. 
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(–) −2−[2Sp−(5,5−Diphenyl−ferrocenyl](6aS,6bS)−6a,6b,7,8,9,11−hexahydro−5H− 
pyrrolo[1',2':3,4]imidazol−2−ylidene)diformylrhodium(IV) chloride (123). 
 
A solution of 122 (14.0 mg, 0.02 mmol) in PhMe (1 mL) was 
saturated led with carbon monoxide for 20 minutes, and then placed 
in an autoclave. After evacuating and refilling 3 times with carbon 
monoxide, the autoclave was pressurized to 15 bar for 18 h. The volatiles were removed 
under reduced pressure and purification by flash column chromatography (silica gel, 
85:15  hexanes/EtOAc  Rf = 0.1) afforded 123 (7 mg, 0.011 mmol, 54%) as yellow 
powdery solid; [α]D
20
 –248 (c 0.4, acetone); IR (CHCl3) νmax 3020, 2991, 2929, 2086, 
2007, 1527, 1492, 1271 cm
–1
; 
1
H NMR (600 MHz, acetone−d6) δ7.85 (d, 2H, J= 7.8 Hz), 
7.61 (t, 2H, J = 7.2 Hz), 7.49 (t, 1H, J = 7.2 Hz), 7.21−7.15 (m, 3H), 6.95−6.92 (m, 2H), 
6.02 (d, 1H, J = 4.8 Hz), 5.84 (s, 1H), 4.31 (s, 1H), 4.31−4.25 (m, 2H), 4.23 (s, 1H), 3.84 
(s, 5H), 3.59−3.54 (m, 1H), 2.46−2.43 (m, 1H), 2.27−2.24 (m, 1H), 2.18−2.15 (m, 1H), 
1.85 (m, 1H); 
13
C NMR (150.9 MHz, acetone−d6) δ 199.1 (d, J = 40.7 Hz), 186.9 (d, J = 
52.8 Hz), 183.0 (d, J = 75.4 Hz), 146.6, 144.8, 128.9, 128.8, 128.8, 128.6, 128.5, 128.4, 
127.3, 94.2, 90.0, 84.6, 83.5, 71.2, 70.3, 69.4, 66.3, 65.2, 62.2, 46.4, 27.5, 25.2; FABMS 
[m/z (%)] 668 (M
+
,7), 640 (26), 136 (18), 121 (23), 69 (55), 55 (99), 43 (100), 41 (88); 
HRMS (FAB) calcd for C31H26N2O3Cl
56
FeRh: 668.0036; found 667.9966. 
Rhodium Hydroformylation of allyl benzene with Rhodium complex 123. 
A solution of rhodium catalyst precursor 122 (7 mg, 1 mol %) in toluene (2 mL) in a vial 
was sparged with carbon monoxide for 20 minutes, and then sealed in an autoclave. The 
autoclave was evacuated and refilled with carbon monoxide three times, pressurized to 15 
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bar, and the mixture was stirred for 6 hours at room temperature. After confirmation by 
TLC that the active catalyst 123 was formed, allyl benzene (0.07 mL, 0.5 mmol), and 
phosphite/ phosphine (1 mol %) were added. The vial was placed in the autoclave, and 
following three evacuations and refills with syngas (1:1 CO:H2), was pressurized to 20 
bar and stirred at 60 °C for 43 hours. The solvent was removed under reduced pressure 
and the crude reaction mixture was transferred to a nitrogen purged flask. Ethanol (2 mL) 
and sodium borohydride (76 mg, 2 mmol) were added, and the extent of reduction was 
monitored by TLC. The reaction mixture was quenched with saturated NH4Cl, and 
volatiles removed under reduced pressure. The crude residue was taken up in CH2Cl2, 
washed with water, dried over Na2SO4, filtered and concentrated. Purification by flash 
column chromatography with silica gel, eluting with 70:30 hexanes/EtOAc provided 
126b and 126l as a mixture of clear colourless oils. Ratios of branched to linear alcohols 
were determined by integration of signals in the combined alcohol 
1
H NMR spectrum. 
The enantiomeric ratio of branched alcohols was determined by HPLC on a Chiralcel 
OD−H, 250 x 4.6 mm, 95:5 n−hexane: 2−propanol, 0.5 ml/min, 210 nm, tR[(–)−(S)] = 
16.4 min, tR[(+)−(R)] = 19.8 min, tR[linear] = 23.5 min.  
 2−Methyl−3−phenylpropan−1−ol (126b).  1H NMR (300 MHz, CDCl3):  = 0.90 (d, J 
= 6.8 Hz, 3H), 1.43 (br s, 1H), 1.87−1.99 (m, 1H), 2.41 (dd, J = 13.4, 
8.1 Hz, 1H), 2.74 (dd, J = 13.4, 6.3 Hz, 1H), 3.46 (dd, J = 10.6, 6.0 Hz, 1H), 3.52 (dd, J = 
10.6, 5.9 Hz, 1H), 7.14−7.28 (m, 5H). 
4−Phenylbutan−1−ol (126l).  1H NMR (300 MHz, CDCl3): = 1.38 (br s, 1H), 1.55− 
1.72 (m, 4H), 2.62 (t, J = 7.5 Hz, 2H), 3.64 (t, J = 6.4 Hz, 2H), 
7.15−7.28 (m, 5H). 
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(S)−2−benzyltetrahydro−1H−pyrrolo[1,2−c]imidazole−1,3(2H)−dione (119). 
          A solution of 48 (5.0 g, 35.69 mmol) in DMF (25 mL) was 
added slowly by cannula to a suspension of NaH (770 mg, 32.1 
mmol) in DMF (15 mL) at 0 °C, and the mixture was stirred for 30 
minutes before the addition of benzyl chloride (4.52 g, 4.10 mL) by syringe. The 
resulting white suspension was allowed to stir for 5 hours at room temperature. The 
reaction mixture was worked up by addition of saturated NH4Cl solution, and diluted 
with diethyl ether. The organic layer was washed with water (6 × 20 mL), dried over 
Na2SO4, filtered and concentrated under reduced pressure. Purification with flash column 
chromatography (silica gel, 1:1 EtOAc:hexanes, Rf = 0.4) gave a colourless crystalline 
solid,  that was recrystallized (EtOH/hexane) to give 119 (5.23 g, 64 %) as clear needles; 
mp 80−82 °C (EtOH/hexane); [α]D
20
 −96.1 (c 1.0, CHCl3); IR (solid, ATR) νmax 2979, 
2929, 2889, 2872, 1763, 1695, 1526, 1494, 1476, 1408 cm
−1
; 
1
H NMR (400 MHz, 
CDCl3) δ 7.37−7.24 (m, 5H), 4.61 (s, 2H), 4.07 (t, 1H, J = 7.65 Hz), 3.67 (dt, 1H, J = 
11.21, 7.68 Hz), 3.25−3.20 (m, 1H), 2.25−2.18 (m, 1H), 2.09−2.01 (m, 2H), 1.68−1.60 
(m, 1H) ;
 13
C NMR (100.7 MHz, CDCl3) δ 173.8, 160.7, 136.3,128.9, 128.7, 128.1, 63.7, 
45.7, 42.8, 27.7, 27.3; EIMS [m/z (%)] 230 (M
+
, 61), 133 (15) 91 (43), 70 (100). Anal. 
calcd for C13H14N2O2; C, 67.81; H, 6.13; Found: C, 67.99; H, 6.12.    
(−)(1R,7aS)−2−Benzyl−1−((triethylsilyl)oxy)tetrahydro−1H−pyrrolo[1,2−c]imidazol
−3(2H)−one (120). 
 Hydantoin 119 (1.00 g, 4.34 mmol) and Schwartz’s reagent (1.45 
g, 5.64 mmol) were suspended in THF (40 mL). The reaction 
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mixture was stirred at room temperature for 15 minutes, during which time the 
suspension became a homogenous solution, indicating consumption of starting material. 
Imidazole (680 mg, 9.98 mmol) and DMAP (48 mg, 0.39 mmol) were added as solids by 
rapid removal and replacement of the septum, and the reaction mixture was treated with 
TESCl (1.09 mL, 6.51 mmol). The reaction mixture was stirred at room temperature for 
an additional 16 hours, and worked up with water (20 mL), and dilution with diethyl 
ether (50 mL). The organic phase was washed with 10% CuSO4 solution (2× 20 mL), 
saturated NaHCO3 (20 mL), and water (20 mL). The resulting tan precipitate was 
removed by filtration through a pad of Celite. The filtrate was dried over Na2SO4, 
filtered, and concentrated under reduced pressure. Flash column chromatography 
(preadsorbed on silica gel after dissolution with CH2Cl2) (silica gel, 7:3 hexane/EtOAc, 
Rf = 0.3) provided 120 as a pale yellow oil (1.24 g, 83%); [α]D
20 
 −71.2 (c 1.0, CHCl3); IR 
(neat, ATR) νmax  2953, 2910, 2875,1703, 1437, 1417, 1323, 1268, 1092 cm
−1
; 
1
H NMR 
(400 MHz, acetone−d6) δ 7.35−7.24 (m, 5H), 5.33 (d, 1H, J = 6.6 Hz); 4.69 (d, 1H, J  = 
16.2 Hz); 4.06 (d, 1H, J = 16.2 Hz); 3.93 (q, 1H, J = 6.8 Hz); 3.56−3.52 (m, 1H); 
3.02−2.98 (m, 1H); 1.90−1.75 (m, 4H); 0.91 (t, 9H, J = 8.0 Hz); 0.61 (q, 6H, J = 7.7 Hz); 
13
C NMR (100.7 MHz, acetone−d6) δ 162.3, 139.5, 129.4, 128.0, 80.7, 63.1, 46.8, 44.2, 
26.8, 26.0, 7.2, 5.4; EIMS [m/z (%)] 346 (M
+
, 9), 317 (100) 222 (30), 145 (147), 133 
(49), 109 (32); HRMS (EI) calcd for C19H30N2O2Si: 346.2077; found 346.2072. 
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(1R,7aS)-2-((S)-phenyl(trimethylsilyl)methyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (121a) 
       To a solution of 120 (105 mg, 0.3 mmol) and TMEDA (0.05 
mL, 0.33 mmol)  in PhMe (2 mL) at –78 °C was added n−BuLi 
(0.17 mL, 1.9 M in hexanes, 0.33 mmol). After stirring for 1 hour, 
the solution changed from clear and colourless to a deep yellow colour. The solution was 
quenched with TMSCl (0.04 mL, 0.33 mmol) and stirred for 1 hour at –78 °C, before 
slowly warming to room temperature.  The reaction mixture was worked up with water 
(0.5 mL), and extracted with diethyl ether (2 × 10 mL). The combined organic extract 
was washed with water, brine, dried over Na2SO4 and concentrated under reduced 
pressure. Purification by flash column chromatography (silica gel, 80:20 hexanes/EtOAc, 
Rf = 0.3) afforded 121a (64 mg, 51%), a clear, colourless oil, as a 7:1 mixture of 
diastereomers.  
(S)-major isomer:   IR (neat, ATR) νmax 2954, 2914, 2876, 1706, 1433, 1243, 1114, 
1095 cm
−1
; 
1
H NMR (400 MHz, acetone−d6) δ 7.31−7.14 (m, 5H), 5.10 (d, 1H, J = 6.8 
Hz)  3.59−3.55 (m, 1H), 3.01−2.95 (m, 1H), 1.89−1.70 (J = 7.0 Hz), 3.84 (s, 1H), 
3.59−3.55 (m, 1H), 3.00−2.95(m, 1H), 1.89−1.70 (m, 4H), 0.98 (t, 9H, J = 8.0 Hz);  0.67 
(q, 6H, J = 7.8 Hz), 0.05 (s, 9H); 
13
C NMR (100.7 MHz, acetone−d6) δ 163.4, 142.4, 
129.2, 128.5, 127.9, 127.7, 126.8, 125.7, 80.0, 63.4, 49.8, 47.3, 26.2, 26.1, 7.3, 5.6, −0.4; 
EIMS [m/z (%)] 418; HRMS (EI) calcd for C22H38N2O2Si: 418.2472; found 418.2476.  
74 
 
(R)-minor isomer: Characteristic signals: 
1H NMR (400 MHz, acetone−d6) δ 5.45 (d, 
1H, J = 7.2 Hz), 3.86 (s, 1H), −0.09 (s, 9H); 13C NMR (100.7 MHz, acetone−d6) δ 8.0, 
4.5, −0.08. 
(1R,7aS)-2-((S)-phenyl(tributylstannyl)methyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (121b). 
 To a solution of 120 (106 mg, 0.31 mmol) and TMEDA (0.05 mL, 
0.34 mmol) in PhMe (2 mL) at –78 °C was added n−BuLi (0.18 
mL, 1.9 M in hexanes, 0.34 mmol). After stirring for 1 hour, the 
solution changed from clear and colourless to a deep yellow colour. The solution was 
quenched with SnBu3Cl (0.09 mL, 0.34 mmol) and stirred for 1 hour at –78 °C, before 
slowly warming to room temperature.  The reaction mixture was worked up with water 
(0.5 mL), and extracted with diethyl ether (2 × 10 mL). The combined organic extract 
was washed with water, brine, dried over Na2SO4, and concentrated under reduced 
pressure. Flash column chromatography (silica gel, 90:10 hexanes/EtOAc, Rf  = 0.6) 
afforded 120b (112 mg, 57%), a clear colourless oil, as a 10:1 mixture of diastereomers.  
(S)-major isomer:  IR (neat, ATR) νmax  2953, 2916, 2873, 1689, 1662, 1491, 1437, 
1276, 1118, 1077 cm
–1
; 
1
H NMR (400 MHz, acetone−d6) δ 7.30 (t, 2H, J = 7.6 Hz), 7.04 
(t, 1H, 7.0 Hz), 7.02 (d, 2H, J = 7.0 Hz), 5.28 (d, 1H, J = 6.9 Hz), 4.12 (s, 1H), 3.98−3.96 
(m, 1H), 3.65−3.55 (m, 1H), 1.95−1.75 (m, 4H), 1.49−1.42 (m, 6H), 1.28 (sex, 6H, J = 
7.3 Hz), 1.00 (t, 9H, J = 8.0 Hz), 0.85 (m, 18H), 0.63 (q, 6H, J = 7.8 Hz); 
13
C NMR 
(100.7 MHz, acetone−d6) δ 164.1, 145.1, 129.3, 125.5, 80.5, 63.0, 47.2, 44.2, 26.4, 26.0, 
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14.2, 13.2, 7.3, 5.5. EIMS [m/z (%)] 579 (M−Bu, 100); HRMS (EI) calcd for 
C27H47N2O2SiSn: 579.2429; found 579.2434. 
(R)-minor isomer: Characteristic signals 
1H NMR (400 MHz, acetone−d6) δ 5.60 (d, 1H, 
J = 6.92 Hz), 4.20 (s, 1H). 
(1R,7aS)-2-((S)-phenyl(trimethylstannyl)methyl)-1-((triethylsilyl)oxy)tetrahydro-
1H-pyrrolo[1,2-c]imidazol-3(2H)-one (121c) 
 To a solution of 120 (105 mg, 0.30  mmol) and TMEDA (0.05 mL, 0.33 
mmol) in PhMe (2 mL) at –78 °C was added n−BuLi (0.17 mL, 1.9 
M in hexanes, 0.33 mmol).  After stirring for 1 hour, the solution changed from clear and 
colourless to a deep yellow colour. The solution was quenched with SnMe3Cl (0.33 mL, 
1.0 M in THF, 0.33 mmol) and stirred for 1 hour at –78 °C, before slowly warming to 
room temperature.  The reaction mixture was worked up with water (0.5 mL), and 
extracted with diethyl ether (2 × 10 mL). The combined organic extract was washed with 
water, brine, dried over Na2SO4, and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 70:30 hexanes/EtOAc, Rf = 0.64) afforded a 10:1 mixture of 
diastereomers, (65 mg, 43%) as a clear, colourless oil.  
(S)-major isomer:  IR (neat, ATR) νmax  2954, 2910, 2876, 1688, 1579, 1435, 1155, 
1048, 1002 cm
−1
; 
1
H NMR (400 MHz, acetone−d6) δ 7.28 (t, 2H, J = 7.7 Hz), 7.10 (t, 1H, 
J = 7.2 Hz), 6.99 (d, 2H, J = 7.3 Hz), 5.25 (d, 1H, J = 6.8 Hz), 3.99 (s, 1H), 3.95(m, 1H), 
3.55−3.52 (m, 1H), 3.0−3.03 (m, 1H), 1.92−1.77 (m, 4H), 0.95 (t, 9H, J = 8.0 Hz), 
0.62(q, 6H, J = 7.8 Hz); 
13
C NMR (100.7 MHz, acetone−d6) δ 164.2, 129.4, 125.5, 80.9, 
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62.9, 47.1, 45.7, 26.7, 26.0, 7.2, 5.5, −6.3. EIMS [m/z (%)] 495 (M−Me, 85); HRMS (EI) 
calcd for C21H35N2O2SiSn: 495.1490; found 495.1501. 
(R)-minor isomer: Characteristic signals 
1H NMR (400 MHz, acetone−d6) δ 5.60 (d, 1H, 
J = 6.8 Hz), 4.10 (s, 1H). 
(1R,7aS)-2-(phenyl(triphenylstannyl)methyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (121d) 
 To a solution of 120 (109 mg, 0.31 mmol) and TMEDA (0.05 mL, 
0.35 mmol) in PhMe (2 mL) at –78 °C was added n−BuLi (0.15 
mL, 1.9 M in hexanes, 0.35 mmol). After stirring for 1 hour, the 
solution changed from clear and colourless to a deep yellow colour. The solution was 
quenched with a solution of SnPh3Cl (135 mg, 0.35 mmol) in PhMe (2 mL) by slow 
cannula transfer, and stirred  for 1 hour at –78 °C, before slowly warming to room 
temperature.  The reaction mixture was worked up with water (0.5 mL), and extracted 
with diethyl ether (2 × 10 mL). The combined organic extract was washed with water, 
brine, dried over Na2SO4, and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 90:10 hexanes/EtOAc, Rf = 0.3) afforded 121d (165 mg, 
76%), a colourless glassy solid, as a 1:1 mixture of diastereomers. IR (solid, ATR) νmax 
3061, 3046, 2953, 2935, 2909, 2875, 1673, 1599, 1578, 1491, 1479,1456, 1440, 1357, 
1342, 1327, 1296, 1275, 1239, 1188, 1155, 1122, 1071, 1048 cm
−1
; 
1
H NMR (400 MHz, 
acetone−d6) δ 7.52−6.93 (m, 40 H, both isomers); 5.81 (d, 1H, J = 7.2 Hz), 5.42 (d, 1H, J 
= 7.2 Hz), 4.73 (s, 1H), 4.68 (s, 1H), 3.97 (q, 1H, J = 8.0 Hz), 3.95 (q, 1H, J = 8.0 Hz), 
3.69 (m, 1H), 3.45 (m, 1H), 3.12 (m, 1H), 3.10 (m, 1H), 1.98−1.71 (m, 9H, both 
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isomers), 0.97 (t, 9H, J  = 8.0 Hz ), 0.79 (t, 9H, J = 8.0 Hz ), 0.65 (q, 6H, J = 8.0 Hz ), 
0.50−0.35 (m, 6H); 13C NMR (100.7 MHz, acetone−d6) δ  164.4, 164.4, 144.9, 143.8, 
143.5, 142.8, 138.5, 138.2, 138.2, 138.0, 129.2, 129.1, 128.8, 128.5, 128.4, 126.3, 126.2, 
126.1, 125.2, 84.6, 80.8, 63.4, 63.1, 50.9, 48.0, 47.0, 46.5, 26.5, 26.4, 26.0, 25.8, 7.3, 7.1, 
5.5, 5.2. EIMS [m/z (%)] 696 (M
+
, 10); HRMS (EI) calcd for C37H44N2O2SiSn: 
696.2194; found 696.2180. 
(1R,7aS)-2-((S)-(methylthio)(phenyl)methyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (121e) 
 To a solution of 120 (103 mg, 0.30 mmol) and TMEDA (0.05 mL, 
0.33 mmol)  in PhMe (2 mL) at –78 °C was added n−BuLi (0.17 
mL, 1.9 M in hexanes, 0.33 mmol). After stirring for 1 hour, the 
solution changed from clear and colourless to a deep yellow colour. The solution was 
quenched with (SMe)2 (0.03 mL, 0.33 mmol)  and stirred  for 1 hour at –78 °C, before 
slowly warming to room temperature.  The reaction mixture was worked up with water 
(0.5 mL), and extracted with diethyl ether (2 × 10 mL). The combined organic extract 
was washed with water, brine, dried over Na2SO4, and concentrated under reduced 
pressure. Flash column chromatography (silica gel, 70:30 hexanes/EtOAc, Rf  = 0.3) 
afforded 121e (101 mg, 86%), a clear colourless oil, as a 8.8:1 mixture of diastereomers.  
(S)-major isomer:  IR (neat, ATR) νmax  2954, 2911, 2875, 1672, 1492, 1479, 1439, 
1425, 1413, 1239, 1121, 1072 cm
−1
; 
1
H NMR (400 MHz, acetone−d6) δ 7.52 (d, 2H, J = 
8.0 Hz), 7.35 (t, 2H, 8.0 Hz), 7.21 (d, 1H, J = 8.0 Hz), 6.22 (s, 1H), 5.85 (d, 1H, J  = 7.1 
Hz), 3.96 (q, 1H, J = 6.8 Hz), 3.63 (dt, J= 11.7, 7.0 Hz), 3.10−3.00 (m, 1H), 2.10 (s, 3H), 
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1.95−1.78 (m, 4H), 0.81 (t, 9H, J = 7.9 Hz), 0.63−0.4 (m, 6H); 13C NMR (100.7 MHz, 
acetone−d6) δ 162.6, 140.7, 128.4, 128.0, 79.0, 64.1, 63.3, 47.1, 26.5, 26.1, 14.5, 7.1, 5.3. 
EIMS [m/z (%)] 261(M−TES, 100); HRMS (EI) calcd for C14H17N2OS: 261.1066; found 
261.1062. 
(R)-minor isomer:   Characteristic signals 
1H NMR (400 MHz, acetone−d6) δ 6.05 (s, 
1H). 5.35 (d, 1H, J= 7.1 Hz), 2.16 (s, 3H). 
(1R,7aS)-2-((S)-1-phenylethyl)-1-((triethylsilyl)oxy)tetrahydro-1H-pyrrolo[1,2-
c]imidazol-3(2H)-one (120f) using MeI as  the electrophile 
 
 
 
 To a solution of 120 (102 mg, 0.29  mmol) and TMEDA (0.05 mL, 0.32 mmol) in PhMe 
(2 mL) at –78 °C was added n−BuLi (0.17 mL, 1.9 M in hexanes, 0.32 mmol). After 
stirring for 1 hour, the solution changed from clear and colourless to a deep yellow 
colour. The solution was quenched with MeI (0.02 mL, 0.32 mmol) and stirred for 1 hour 
at –78 °C, before slowly warming to room temperature.  The reaction mixture was 
worked up with water (0.5 mL), and extracted with diethyl ether (2 × 10 mL). The 
combined organic extract was washed with water, brine, dried over Na2SO4, and 
concentrated under reduced pressure. Flash column chromatography (silica gel, 70:30 
hexanes/EtOAc, Rf = 0.3) afforded 121f (84 mg, 81%) a clear colourless oil, as a 4.5:1 
mixture of diastereomers.  
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(S)-major isomer: IR (neat, ATR) νmax  2953, 2910, 2876, 1673, 1421, 1376, 1326, 
1276, 1239 cm
–1
; 
1
H NMR (400 MHz, acetone−d6) δ 7.43 (d, 2H, J = 7.6 Hz), 7.28 (t, 
2H, J = 7.2 Hz), 7.22 (t, 1H, J = 7.2 Hz), 5.53 (d, 0.72 H, J = 6.9 Hz), 4.66 (q, 1H, J = 7.3 
Hz), 3.88 (q, 1H, J = 7.0 Hz), 3.59−3.56 (m, 1H), 2.98−2.95 (m, 1H), 2.08−1.90 (m, 4H), 
1.77 (d, 3H, J = 7.2 Hz), 0.97 (t, 9H, J = 7.9 Hz), 0.73−0.67 (m, 6H) ; 13C NMR (100.7 
MHz, acetone−d6) δ 161.9, 144.7, 128.9,127.8,127.5, 81.2, 63.3, 53.0,46.9, 26.2, 19.8, 
7.2, 5.5. EIMS [m/z (%)] 360(M
+
, 23), 317(26), 124(80), 105(100), 103(48), 77(28); 
HRMS (EI) calcd for C20H32N2O2Si: 360.2233; found 360.2241.  
(R)-minor isomer: Characteristic signals 
1H NMR (400 MHz, acetone−d6) δ 5.35 (d, 1H, 
J= 7.2 Hz), 4.95 (Q, 1h, J = 7.3 Hz), 1.68 (d, 3H, J = 7.3 Hz). 
(1R,7aS)-2-((S)-1-phenylethyl)-1-((triethylsilyl)oxy)tetrahydro-1H-pyrrolo[1,2-
c]imidazol-3(2H)-one (121f) using Me2SO4 as the electrophile 
 
 
 
 To a solution of 120 (112 mg, 0.32 mmol) and TMEDA (0.05 mL, 0.36 mmol) in PhMe 
(2 mL) at –78 °C was added n−BuLi (0.19 mL, 1.9 M in hexanes, 0.36 mmol). After 
stirring for 1 hour, the solution changed from clear and colourless to a deep yellow 
colour. The solution was quenched with Me2SO4 (0.03 mL, 0.36 mmol) and stirred for 1 
hour at –78 °C, before slowly warming to room temperature.  The reaction mixture was 
worked up with water (0.5 mL), and extracted with diethyl ether (2 × 10 mL). The 
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combined organic extract was washed with water, brine, dried over Na2SO4, and 
concentrated under reduced pressure. Flash column chromatography (silica gel, 70:30 
hexanes/EtOAc, Rf = 0.3) afforded 121f (64 mg, 51%) a clear colourless oil, as a 7:1 
mixture of diastereomers. All spectroscopic data matched those of 121f above.  
(1R,7aS)-2-((R)-2-hydroxy-1,2,2-triphenylethyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (121g) 
 To a solution of 121g (111 mg, 0.32 mmol) and TMEDA (0.05 
mL, 0.35 mmol) in PhMe (2 mL) at –78 °C was added n−BuLi 
(0.19 mL, 1.9 M in hexanes, 0.35 mmol). After stirring for 1 hour, 
the solution changed from clear and colourless to a deep yellow colour. The solution was 
quenched with a solution of Ph2CO (64 mg, 0.35 mmol) in PhMe (1 mL) by slow cannula 
transfer. The deep yellow solution turned to lime green after quench. The resulting 
reaction mixture was stirred for 1 hour at –78 °C, before slowly warming to room 
temperature. The reaction mixture was worked up with water (0.5 mL), and extracted 
with diethyl ether (2 × 10 mL). The combined organic extract was washed with water, 
brine, dried over Na2SO4, and concentrated under reduced pressure. Flash column 
chromatography (silica gel, 90:10 hexanes/EtOAc, Rf = 0.18) afforded 121g (77 mg, 
46%) a white crystalline solid, as an 11:1 mixture of diastereomers. Recrystallization 
from ethanol/hexane provided (R)-121g as fine colourless needles, ≥ 95:5 dr by 1H NMR.  
(R)-major isomer:  mp 157−158 °C (EtOH/hexane); [α]D
20
 +292 (c 1.0, acetone); X-ray 
diffractometry was performed on a single clear, colourless crystal (0.21 × 0.20 × 0.12 
mm
3
), which was obtained by crystallization from ethanol/hexanes: C32H40N2O3Si: M = 
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528.75 g/mol, orthorhombic, P212121, a = 9.6422(5) Å,  b = 16.6071(8) Å,  c = 
36.8350(17) Å, V = 5898.4(5) Å
3
, α = 90°, β = 90°, γ = 90°, Z = 8, Dc =   1.191 mg/ m
3
, 
F(000)
 
= 2272, T = 147 (2)  K; 240498 data were collected. The structure was solved by 
Direct Methods (SHELXTL) and refined by full-matrix least squares on F
2
 resulting in 
final R, Rw, and GOF [ for 10465 data with F > 2σ(F)] of 0.0371, 0.0943, and 1.023 
respectively, Flack parameter = 0.02(3); 
 
IR (solid, ATR) νmax 3192, 2957, 2935, 2909, 
2876, 1675, 1447, 1429, 1266, 1138 cm
−1
; 
1
H NMR (400 MHz, acetone−d6) δ 8.04 (s, 
1H); 7.90 (d, 2H, J = 7.6 Hz); 7.30 (m, 4H), 7.17 (m, 2H), 7.08 (m, 5H), 6.85 (d, 2H, J = 
7.2 Hz), 5.27 (s, 1H), 5.13 (d, 1H, J = 7.1 Hz), 3.78 (q, 1H, J = 7.6 Hz), 3.36 (m, 1H), 
2.87−2.80 (m, 1H), 1.74−1.71 (m, 3H), 1.06 (t, 9H, J = 8.0 Hz), 0.77 (q, 6H, J = 7.9 Hz); 
13
C NMR (100.7 MHz, acetone−d6) δ 163.8, 148.4, 146.8, 138.0, 130.5, 129.0, 128.2, 
128.1, 128.0, 127.8, 127.6, 127.5, 127.2, 127.1, 80.7, 79.5, 65.6, 63.8, 47.5, 25.7, 24.9, 
7.3, 5.5. Anal. calcd for C32H40N2O3Si; C, 72.69; H, 7.62; Found: C, 72.50; H, 7.65.  
(S)-minor isomer: Characteristic signals: 
1H NMR (400 MHz, acetone−d6) δ 5.85 (s, 
1H). 4.85 (d, 1H, J = 7.0 Hz). 
(1R,7aS)-2-((S)-1-phenylethyl)-1-((triethylsilyl)oxy)tetrahydro-1H-pyrrolo[1,2-
c]imidazol-3(2H)-one (121f) formed from transmetalation of (121c) 
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 To a solution of 121c (165 mg, 0.32 mmol) and TMEDA (0.05 mL, 0.36 mmol) in PhMe 
(2 mL) at –78 °C was added n−BuLi (0.19 mL, 1.9 M in hexanes, 0.36 mmol). After 
stirring for 1 hour, the solution changed from clear and colourless to a deep yellow 
colour. The solution was quenched with MeI (0.02 mL, 0.36 mmol) and stirred for 1 hour 
at –78 °C, before slowly warming to room temperature. The reaction mixture was worked 
up with water (0.5 mL), and extracted with diethyl ether (2 × 10 mL). The combined 
organic extract was washed with water, brine, dried over Na2SO4, and concentrated under 
reduced pressure. Flash column chromatography (silica gel, 70:30 hexanes/EtOAc, Rf = 
0.3) afforded 121f (84 mg, 73%) a clear colourless oil, as a 5:1 mixture of diastereomers. 
All spectroscopic data matched those of 121f from direct quench above.  
 (1R,7aS)-2-((S)-phenyl(trimethylsilyl)methyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one formed from transmetalation of (121b)  
 
 
 
 To a solution of 121b (125mg, 0.20 mmol) and TMEDA (0.03 mL, 0.22 mmol) in PhMe 
(2 mL) at –78 °C was added n−BuLi (0.09 mL, 1.9 M in hexanes, 0.22 mmol). After 
stirring for 1 hour, the solution changed from clear and colourless to a deep yellow 
colour. The solution was quenched with SiMe3Cl (0.03 mL, 0.22 mmol) and stirred for 1 
hour at –78 °C before slowly warming to room temperature. . The reaction mixture was 
worked up with water (0.5 mL), and extracted with diethyl ether (2 × 10 mL). The 
combined organic extract was washed with water, brine, dried over Na2SO4, and 
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concentrated under reduced pressure. Flash column chromatography (silica gel, 80:20 
hexanes/EtOAc, Rf = 0.3) afforded 121a (45 mg, 54%) a clear colourless oil, as a 10:1 
mixture of diastereomers. All spectroscopic data matched those of 121a from direct 
quench above. 
(1R,7aS)-2-((R)-2-hydroxy-1,2,2-triphenylethyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (121g) from transmetalation of (121b) 
 
 
 
To a solution of 121b (127 mg, 0.20 mmol) and TMEDA (0.03 mL, 0.22 mmol) in PhMe 
(2 mL) at –78 °C was added n−BuLi (0.12 mL, 1.9 M in hexanes, 0.22 mmol). After 
stirring for 1 hour, the solution changed from clear and colourless to a deep yellow 
colour. The solution was quenched with a solution of Ph2CO (40 mg, 0.22 mmol) in 
PhMe (1 mL) by slow cannula transfer. The deep yellow solution turned to lime green 
after quench. The resulting reaction mixture was stirred for 1 hour at –78 °C, before 
slowly warming to room temperature. The reaction mixture was worked up with water 
(0.5 mL), and extracted with diethyl ether (2 × 10 mL). The combined organic extract 
was washed with water, brine, dried over Na2SO4, and concentrated under reduced 
pressure. Flash column chromatography (silica gel, 90:10 hexanes/EtOAc, Rf = 0.18) 
afforded 121g (52 mg, 50%) a white crystalline solid, as a 10:1 mixture of diastereomers. 
All spectroscopic data those of 121g from direct quench above. 
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(1R,7aS)-2-(Deutero(phenyl)methyl)-1-((triethylsilyl)oxy)tetrahydro-1H-pyrrolo 
[1,2-c]imidazol-3(2H)-one (120d) 
 To a solution of 120 (111 mg, 0.32 mmol) and TMEDA (0.05 mL, 
0.35 mmol) in PhMe (2 mL) at –78 °C was added n−BuLi (0.19 
mL, 1.9 M in hexanes, 0.35 mmol). After stirring for 1 hour, the solution changed from 
clear and colourless to a deep yellow colour. The solution was quenched with MeOH-d4 
(0.2 mL). A colour change from deep yellow to white, opaque was observed. The 
resulting reaction mixture was stirred for 5 minutes at –78 °C before workup with 
saturated NH4Cl, and extraction with diethyl ether (2 × 10 mL). The combined organic 
extract was washed with water, brine, dried over anhydrous Na2SO4 and concentrated 
under reduced pressure. Purification by flash column chromatography (silica gel, 70:30 
hexanes/EtOAc, Rf = 0.18) afforded 120-d (140 mg, 70%) as a pale yellow oil. IR (neat, 
ATR) νmax 2953, 2910, 2875,1703, 1437, 1417, 1323, 1268, 1092 cm
−1
 
1
H NMR (400 
MHz, acetone−d6) δ 7.34-7.31 (m, 2H), 7.27-7.24 (m, 3H), 5.33 (d, 1H, J = 6.6 Hz), 4.05 
(s, 1H), 3.95 (q, 1H, J = 7.2 Hz), 3.55-3.52 (m, 1H), 3.02-2.70 (m, 1H), 2.04-1.86 (m, 
3H), 1.76-1.75 (m, 1H), 0.93 (t, 9H, J = 7.6 Hz), 0.59 (q, 6H, J = 7.9 Hz); 
13
C NMR 
(100.7 MHz, acetone−d6) δ 162.3, 139.5, 129.4, 128.1, 127.9, 80.8, 63.2, 46.9, 44.0 (t, J 
= 21.2 Hz), 26.8, 26.0, 7.2, 5.5. EIMS [m/z (%)] 347 (M
+
, 3), 103 (100); HRMS (EI) 
calcd for C19H29N2O2Si: 347.2139; found 347.2127. 
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(1R,7aS)-2-((R)-2-hydroxy-1,2,2-triphenylethyl)-1-((triethylsilyl)oxy)tetrahydro-1H-
pyrrolo[1,2-c]imidazol-3(2H)-one (121g) from 120-d. 
 
 To a solution of 120-d (135 mg, 0.39 mmol) and TMEDA (0.06 mL, 0.43 mmol) in 
PhMe (2 mL) at –78 °C was added n−BuLi (0.19 mL, 1.9 M in hexanes, 0.35 mmol). 
After stirring for 1 hour, the solution changed from clear and colourless to a deep yellow 
colour. The solution was quenched with a solution of Ph2CO (78 mg,0.43 mmol) in PhMe 
(1 mL) by slow cannula transfer. The deep yellow solution turned to lime green after 
quench. The resulting reaction mixture was stirred for 1 hour at –78 °C, before slowly 
warming to room temperature. The reaction mixture was worked up with water (0.5 mL), 
and extracted with diethyl ether (2 × 10 mL). The combined organic extract was washed 
with water, brine, dried over Na2SO4, and concentrated under reduced pressure. Flash 
column chromatography (silica gel, 70:30 hexanes/EtOAc, Rf = 0.52, 0.50) afforded 121g 
(152 mg, 74%), a clear glassy solid, as a 1:1 mixture of diastereomers. The NMR spectral 
data matched those reported previously in both 
1
H and 
13
C NMR. ESI−MS [m/z (%)] 530 
[(M+H)
+
, 100]; HRMS calcd for C32H40N2O2SiD: 530.2949, found 530.2928. 
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(3R,9aS,9bS)-2,2,3-Triphenylhexahydropyrrolo[1',2':3,4]imidazo[5,1-b]oxazol-
5(9bH)-one 124 
 A solution of 121g (100 mg g, 0.19 mmol) and p−toluene sulfonic 
acid (6 mg, 0.03 mmol) in CHCl3 was stirred at room temperature for 30 
minutes. The reaction mixture was quenched with saturated NaHCO3, and the aqueous 
layer extracted with CH2Cl2. The combined organic layer was dried over Na2SO4, filtered 
and concentrated under reduced pressure. Purification by flash column chromatography 
(silica gel, 70:30 hexanes/EtOAc, Rf = 0.20) provided 124 (23 mg, 31%) as a crystalline 
solid; mp 180-183°C (EtOAc/hexane); [α]D
20
 + 43 ( c 1.1 acetone); IR (solid, ATR) νmax 
3088, 3057, 3021, 2975, 2934, 2908, 2851, 1712, 1601, 1587, 1493, 1380, 1323,1252, 
1049 cm
-1
; 
1H NMR (400 MHz, acetone−d6) δ 7.78 (d, 2H, J = 7.6 Hz), 7.33 (t, 2H, J = 
8.0 Hz), 7.26-7.16 (m, 5H), 7.14-7.05 (m, 3H), 6.99-6.92 (m, 3H), 6.03 (s, 1H), 5.93 (s, 
1H), 3.95(dd, 1H, J = 10.0 Hz, 6.8 Hz), 3.28 (dt, 1H, J  = 11.1 Hz, 7.6 Hz), 2.84-2.81 (m, 
2H), 2.16-2.07 (m, 1H), 2.04-1.89 (m, 3H), 1.59-1.55 (m, 1H); 
13
C NMR (100.6 MHz, 
acetone-d6) δ 164.6, 146.3, 143.7, 139.8, 129.4, 128.9, 128.6, 128.3, 128.2, 127.79, 
127.77, 127.6, 127.1, 94.4, 93.4, 70.7, 65.5, 45.9, 26.5.  EIMS [m/z (%)] 394 [M
+−2H, 
5]; HRMS (EI) calcd for C26H22N2O2: 394.1681, found 394.1685. 
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